
<!DOCTYPE html>
<html lang="en" >
    <head >

        <meta charset="UTF-8" />
        <meta http-equiv="X-UA-Compatible" content="IE=edge" />
        <meta name="HandheldFriendly" content="True" />
        <meta name="MobileOptimized" content="320" />
        <meta name="viewport" content="width=device-width, initial-scale=1.0" />

        
        

        
        
  <link rel="stylesheet" href="/static/assets/style-a68b4900.css" />
<script type="module" crossorigin="" src="/static/assets/base_style-0a3f24ce.js"></script>

  <link rel="stylesheet" href="/static/assets/style-ef962842.css" />
<link rel="stylesheet" href="/static/assets/style-3ade8b5c.css" />
<script type="module" crossorigin="" src="/static/assets/article_style-d757a0dd.js"></script>

  
  
    <style>
  
  
  @media screen and (min-width: 64em) {
    div.pmc-wm {
      background: repeat-y;
      background-image: url("data:image/svg+xml,%3Csvg xmlns='http://www.w3.org/2000/svg' width='20' height='350' xmlns:xlink='http://www.w3.org/1999/xlink'%3E%3Cdefs%3E%3Cfilter x='-.02' y='0' width='1.05' height='1' id='c'%3E%3CfeFlood flood-color='%23FFF'/%3E%3CfeComposite in='SourceGraphic'/%3E%3C/filter%3E%3Ctext id='b' font-family='Helvetica' font-size='11pt' style='opacity:1;fill:%23005ea2;stroke:none;text-anchor:middle' x='175' y='14'%3E%3C/text%3E%3Cpath id='a' style='fill:%23005ea2' d='M0 8h350v3H0z'/%3E%3C/defs%3E%3Cuse xlink:href='%23a' transform='rotate(90 10 10)'/%3E%3Cuse xlink:href='%23b' transform='rotate(90 10 10)' filter='url(%23c)'/%3E%3C/svg%3E");
      padding-left: 3rem;
    }
  }
</style>

  



        
            <link rel="apple-touch-icon"
                  sizes="180x180"
                  href="/static/img/favicons/apple-touch-icon.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="48x48"
                  href="/static/img/favicons/favicon-48x48.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="32x32"
                  href="/static/img/favicons/favicon-32x32.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="16x16"
                  href="/static/img/favicons/favicon-16x16.png" />
            <link rel="manifest" href="/static/img/favicons/site.webmanifest" />
            <link rel="mask-icon"
                  href="/static/img/favicons/safari-pinned-tab.svg"
                  color="#0071bc" />
            <meta name="msapplication-config"
                  content="/static/img/favicons/browserconfig.xml" />
            <meta name="theme-color" content="#ffffff" />
        

        <title>
            Efficacy and Safety of Histamine H3 Receptor Antagonist/Inverse Agonist Including Betahistine for Schizophrenia: A Systematic Review and Meta‐Analysis - PMC
        </title>

        
        
  
  <!-- Logging params: Pinger defaults -->
<meta name="ncbi_app" content="cloudpmc-viewer" />
<meta name="ncbi_db" content="pmc" />
<meta name="ncbi_phid" content="4DDE44AE89B6D4131B44AE0042ADE734.m_1" />
<meta name="ncbi_pinger_stat_url" content="https://pmc.ncbi.nlm.nih.gov/stat" />
<!-- Logging params: Pinger custom -->
<meta name="ncbi_pdid" content="article" />
  
    <link rel="preconnect" href="https://www.google-analytics.com" />

    
        <link rel="preconnect" href="https://cdn.ncbi.nlm.nih.gov" />
    

    <!-- Include USWDS Init Script -->
    <script src="/static/assets/uswds-init.js"></script>


    <meta name="ncbi_domain" content="neurorep">
<meta name="ncbi_type" content="fulltext">
<meta name="ncbi_pcid" content="journal">
<meta name="ncbi_feature" content="associated_data">
<link rel="canonical" href="https://pmc.ncbi.nlm.nih.gov/articles/PMC12198695/">
<meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE">
<meta name="citation_journal_title" content="Neuropsychopharmacology Reports">
<meta name="citation_title" content="Efficacy and Safety of Histamine H3 Receptor Antagonist/Inverse Agonist Including Betahistine for Schizophrenia: A Systematic Review and Meta‐Analysis">
<meta name="citation_author" content="Yasufumi Nishii">
<meta name="citation_author_institution" content="Department of Psychiatry, Fujita Health University School of Medicine, Toyoake, Aichi, Japan">
<meta name="citation_author" content="Kenji Sakuma">
<meta name="citation_author_institution" content="Department of Psychiatry, Fujita Health University School of Medicine, Toyoake, Aichi, Japan">
<meta name="citation_author" content="Shun Hamanaka">
<meta name="citation_author_institution" content="Department of Psychiatry, Fujita Health University School of Medicine, Toyoake, Aichi, Japan">
<meta name="citation_author" content="Nakao Iwata">
<meta name="citation_author_institution" content="Department of Psychiatry, Fujita Health University School of Medicine, Toyoake, Aichi, Japan">
<meta name="citation_author" content="Taro Kishi">
<meta name="citation_author_institution" content="Department of Psychiatry, Fujita Health University School of Medicine, Toyoake, Aichi, Japan">
<meta name="citation_publication_date" content="2025 Jun 26">
<meta name="citation_volume" content="45">
<meta name="citation_issue" content="3">
<meta name="citation_firstpage" content="e70034">
<meta name="citation_doi" content="10.1002/npr2.70034">
<meta name="citation_pmid" content="40567153">
<meta name="citation_abstract_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12198695/">
<meta name="citation_fulltext_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12198695/">
<meta name="citation_pdf_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12198695/pdf/NPR2-45-e70034.pdf">
<meta name="description" content="Whether histamine H3 receptor antagonists (H3R‐ANTs)/inverse agonists (H3R‐IAs) provides benefit for the treatment of schizophrenia remains unclear. This meta‐analysis was conducted to address the above clinical question. Cognitive Function Scale&#x27;s ...">
<meta name="og:title" content="Efficacy and Safety of Histamine H3 Receptor Antagonist/Inverse Agonist Including Betahistine for Schizophrenia: A Systematic Review and Meta‐Analysis">
<meta name="og:type" content="article">
<meta name="og:site_name" content="PubMed Central (PMC)">
<meta name="og:description" content="Whether histamine H3 receptor antagonists (H3R‐ANTs)/inverse agonists (H3R‐IAs) provides benefit for the treatment of schizophrenia remains unclear. This meta‐analysis was conducted to address the above clinical question. Cognitive Function Scale&#x27;s ...">
<meta name="og:url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12198695/">
<meta name="og:image" content="https://cdn.ncbi.nlm.nih.gov/pmc/cms/images/pmc-card-share.jpg?_=0">
<meta name="twitter:card" content="summary_large_image">
<meta name="twitter:site" content="@ncbi">
    
    

    </head>
    <body >
        
    <a class="usa-skipnav " href="#main-content">
      Skip to main content
    </a>


        
            

<section class="usa-banner " aria-label="Official website of the United States government" >
    <div class="usa-accordion">
        <header class="usa-banner__header">
            <div class="usa-banner__inner">
                <div class="grid-col-auto">
                    <img aria-hidden="true"
                         class="usa-banner__header-flag"
                         src="/static/img/us_flag.svg"
                         alt="" />
                </div>

                <div class="grid-col-fill tablet:grid-col-auto" aria-hidden="true">
                    <p class="usa-banner__header-text">
                        An official website of the United States government
                    </p>
                    <span class="usa-banner__header-action">Here's how you know</span>
                </div>

                



















    
        <button
            type="button"
        
    
    class="usa-accordion__button usa-banner__button
           

           
               
               
               
               
            

           
           
           
           "
    aria-expanded="false"
    aria-controls="gov-banner-default"
    
    data-testid="storybook-django-banner"
    
    >
    
        

        
                    <span class="usa-banner__button-text">Here's how you know</span>
                

        
    
        
            </button>
        


            </div>
        </header>

        <div class="usa-banner__content usa-accordion__content"
             id="gov-banner-default"
             hidden>
            <div class="grid-row grid-gap-lg">
                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-dot-gov.svg"
                         alt=""
                         aria-hidden="true" />
                    <div class="usa-media-block__body">
                        <p>
                            <strong>Official websites use .gov</strong>
                            <br />
                            A
                            <strong>.gov</strong> website belongs to an official
                            government organization in the United States.
                        </p>
                    </div>
                </div>

                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-https.svg"
                         alt=""
                         aria-hidden="true" />

                    <div class="usa-media-block__body">
                        <p>
                            <strong>Secure .gov websites use HTTPS</strong>
                            <br />
                            A <strong>lock</strong> (
                            <span class="icon-lock">
                                <svg xmlns="http://www.w3.org/2000/svg"
                                     width="52"
                                     height="64"
                                     viewBox="0 0 52 64"
                                     class="usa-banner__lock-image"
                                     role="graphics-symbol"
                                     aria-labelledby="banner-lock-description"
                                     focusable="false">
                                    <title id="banner-lock-title">Lock</title>
                                    <desc id="banner-lock-description">
                                    Locked padlock icon
                                    </desc>
                                    <path fill="#000000"
                                          fill-rule="evenodd"
                                          d="M26 0c10.493 0 19 8.507 19 19v9h3a4 4 0 0 1 4 4v28a4 4 0 0 1-4 4H4a4 4 0 0 1-4-4V32a4 4 0 0 1 4-4h3v-9C7 8.507 15.507 0 26 0zm0 8c-5.979 0-10.843 4.77-10.996 10.712L15 19v9h22v-9c0-6.075-4.925-11-11-11z" />
                                </svg>
</span>) or <strong>https://</strong> means you've safely
                                connected to the .gov website. Share sensitive
                                information only on official, secure websites.
                            </p>
                        </div>
                    </div>
                </div>
            </div>
        </div>
    </section>

        

        
    
    
    

<div class="usa-overlay">
</div>



<header class="usa-header usa-header--extended usa-header--wide" data-testid="header" data-header >
    <div class="ncbi-header">
        <div class="ncbi-header__container">
            
                <a class="ncbi-header__logo-container" href="https://www.ncbi.nlm.nih.gov/">
                    <img alt="
                                  NCBI home page
                              "
                         class="ncbi-header__logo-image"
                         src="/static/img/ncbi-logos/nih-nlm-ncbi--white.svg" />
                </a>
            

            <!-- Mobile menu hamburger button -->
            



















    
        <button
            type="button"
        
    
    class="usa-menu-btn ncbi-header__hamburger-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Show menu"
    data-testid="navMenuButton"
    
    >
    
        

        
                <svg aria-hidden="true"
                     class="ncbi-hamburger-icon"
                     fill="none"
                     focusable="false"
                     height="21"
                     viewBox="0 0 31 21"
                     width="31"
                     xmlns="http://www.w3.org/2000/svg">
                    <path clip-rule="evenodd"
                          d="M0.125 20.75H30.875V17.3333H0.125V20.75ZM0.125 12.2083H30.875V8.79167H0.125V12.2083ZM0.125 0.25V3.66667H30.875V0.25H0.125Z"
                          fill="#F1F1F1"
                          fill-rule="evenodd" />
                </svg>
            

        
    
        
            </button>
        



            
                <!-- Desktop buttons-->
                <div class="ncbi-header__desktop-buttons">
                    
                        <!-- Desktop search button -->
                        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button
           "
    aria-expanded="false"
    aria-controls="search-field-desktop-navigation"
    aria-label="Show search overlay"
    data-testid="toggleSearchPanelButton"
    data-toggle-search-panel-button
    >
    
        

        
                            


    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true"    >
        
        <use xlink:href="/static/img/sprite.svg#search" />
    </svg>


                            Search
                        

        
    
        
            </button>
        


                    

                    <!-- Desktop login dropdown -->
                    
                        <div class="ncbi-header__login-dropdown">
                            



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button ncbi-header__login-dropdown-button
           "
    aria-expanded="false"
    aria-controls="login-dropdown-menu"
    aria-label="Show login menu"
    data-testid="toggleLoginMenuDropdown"
    data-desktop-login-button
    >
    
        

        
                                


    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true"    >
        
        <use xlink:href="/static/img/sprite.svg#person" />
    </svg>



                                <span data-login-dropdown-text>Log in</span>

                                <!-- Dropdown icon pointing up -->
                                


    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-less ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true"    data-login-dropdown-up-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_less" />
    </svg>



                                <!-- Dropdown icon pointing down -->
                                


    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-more ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true"    data-login-dropdown-down-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_more" />
    </svg>


                            

        
    
        
            </button>
        



                            <!-- Login dropdown menu -->
                            <ul class="usa-nav__submenu ncbi-header__login-dropdown-menu"
                                id="login-dropdown-menu"
                                data-desktop-login-menu-dropdown
                                hidden>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        








<a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
    

    Dashboard

    
</a>

                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        








<a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
    

    Publications

    
</a>

                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        








<a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
    

    Account settings

    
</a>

                                    </li>
                                
                                <li class="usa-nav__submenu-item">
                                    



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--outline ncbi-header__login-dropdown-logout-button
           "
    
    
    
    data-testid="desktopLogoutButton"
    data-desktop-logout-button
    >
    
        

        Log out

        
    
        
            </button>
        


                                </li>
                            </ul>
                        </div>
                    
                </div>
            
        </div>
    </div>

    <!-- Search panel -->
    
        <div class="ncbi-search-panel ncbi--show-only-at-desktop"
             data-testid="searchPanel"
             data-header-search-panel
             hidden>
            <div class="ncbi-search-panel__container">
                <form action="https://www.ncbi.nlm.nih.gov/search/all/"
                      aria-describedby="search-field-desktop-navigation-help-text"
                      autocomplete="off"
                      class="usa-search usa-search--big ncbi-search-panel__form"
                      data-testid="form"
                      method="GET"
                      role="search">
                    <label class="usa-sr-only"
                           data-testid="label"
                           for="search-field-desktop-navigation">
                        Search…
                    </label>
                    <input class="usa-input"
                           data-testid="textInput"
                           id="search-field-desktop-navigation"
                           name="term"
                           
                               placeholder="Search NCBI"
                           
                           type="search"
                           value="" />
                    



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    data-testid="button"
    
    >
    
        

        
                        <span class="usa-search__submit-text">
                            Search NCBI
                        </span>
                    

        
    
        
            </button>
        


                </form>

                
            </div>
        </div>
    

    <nav aria-label="Primary navigation" class="usa-nav">
        <p class="usa-sr-only" id="primary-navigation-sr-only-title">
            Primary site navigation
        </p>

        <!-- Mobile menu close button -->
        



















    
        <button
            type="button"
        
    
    class="usa-nav__close ncbi-nav__close-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Close navigation menu"
    data-testid="navCloseButton"
    
    >
    
        

        
            <img src="/static/img/usa-icons/close.svg" alt="Close" />
        

        
    
        
            </button>
        



        
            <!-- Mobile search component -->
            <form class="usa-search usa-search--small ncbi--hide-at-desktop margin-top-6"
                  role="search">
                <label class="usa-sr-only" for="search-field">
                    Search
                </label>

                <input class="usa-input"
                       id="search-field-mobile-navigation"
                       type="search"
                       
                           placeholder="Search NCBI"
                       
                       name="search" />

                



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                    <!-- This SVG should be kept inline and not replaced with a link to the icon as otherwise it will render in the wrong color -->
                    <img src="data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIGhlaWdodD0iMjQiIHZpZXdCb3g9IjAgMCAyNCAyNCIgd2lkdGg9IjI0Ij48cGF0aCBkPSJNMCAwaDI0djI0SDB6IiBmaWxsPSJub25lIi8+PHBhdGggZmlsbD0iI2ZmZiIgZD0iTTE1LjUgMTRoLS43OWwtLjI4LS4yN0E2LjQ3MSA2LjQ3MSAwIDAgMCAxNiA5LjUgNi41IDYuNSAwIDEgMCA5LjUgMTZjMS42MSAwIDMuMDktLjU5IDQuMjMtMS41N2wuMjcuMjh2Ljc5bDUgNC45OUwyMC40OSAxOWwtNC45OS01em0tNiAwQzcuMDEgMTQgNSAxMS45OSA1IDkuNVM3LjAxIDUgOS41IDUgMTQgNy4wMSAxNCA5LjUgMTEuOTkgMTQgOS41IDE0eiIvPjwvc3ZnPg=="
                         class="usa-search__submit-icon"
                         alt="Search" />
                

        
    
        
            </button>
        


            </form>

            
        

        <!-- Primary navigation menu items -->
        <!-- This usa-nav__inner wrapper is required to correctly style the navigation items on Desktop -->
        

        
            <div class="ncbi-nav__mobile-login-menu ncbi--hide-at-desktop"
                 data-mobile-login-menu
                 hidden>
                <p class="ncbi-nav__mobile-login-menu-status">
                    Logged in as:
                    <strong class="ncbi-nav__mobile-login-menu-email"
                            data-mobile-login-email-text></strong>
                </p>
                <ul class="usa-nav__primary usa-accordion">
                    
                        <li class="usa-nav__primary-item">
                            








<a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
    

    Dashboard

    
</a>

                        </li>
                    
                        <li class="usa-nav__primary-item">
                            








<a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
    

    Publications

    
</a>

                        </li>
                    
                        <li class="usa-nav__primary-item">
                            








<a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
    

    Account settings

    
</a>

                        </li>
                    
                </ul>
            </div>
        

        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           ncbi-nav__mobile-login-button ncbi--hide-at-desktop
           "
    
    
    
    data-testid="mobileLoginButton"
    data-mobile-login-button
    >
    
        

        Log in

        
    
        
            </button>
        


    </nav>
</header>

    
    
        

<section class="pmc-header pmc-header--basic" aria-label="PMC Header with search box">
    <div class="pmc-nav-container">
        <div class="pmc-header__bar">
           <div class="pmc-header__logo">
               <a href="/" title="Home" aria-label="PMC Home"></a>
           </div>
            <button
                    type="button"
                    class="usa-button usa-button--unstyled pmc-header__search__button"
                    aria-label="Open search"
                    data-ga-category="search"
                    data-ga-action="PMC"
                    data-ga-label="pmc_search_panel_mobile"
            >
                <svg class="usa-icon width-4 height-4 pmc-icon__open" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#search"></use>
                </svg>
                <svg class="usa-icon width-4 height-4 pmc-icon__close" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
            </button>
        </div>
        <div class="pmc-header__search">
            


<form class="usa-search usa-search--extra usa-search--article-right-column  pmc-header__search__form" id="pmc-search-form" autocomplete="off" role="search">
<label class="usa-sr-only" for="pmc-search">Search PMC Full-Text Archive</label>
<span class="autoComplete_wrapper flex-1">
<input class="usa-input width-full maxw-none" required="required" placeholder="Search PMC Full-Text Archive" id="pmc-search"  type="search" name="term" data-autocomplete-url="https://pmc.ncbi.nlm.nih.gov/autocomp/search/autocomp/"/>
</span>
<button
class="usa-button"
type="submit"
formaction="https://www.ncbi.nlm.nih.gov/pmc/"
data-ga-category="search"
data-ga-action="PMC"
data-ga-label="PMC_search_button"
>
<span class="usa-search__submit-text">Search in PMC</span>
<img
src="/static/img/usa-icons-bg/search--white.svg"
class="usa-search__submit-icon"
alt="Search"
/>
</button>
</form>
            <div class="display-flex flex-column tablet:flex-row tablet:flex-justify flex-justify-center flex-align-center width-full desktop:maxw-44">
                <ul class="pmc-header__search__menu">
                    <li>
                        <a class="usa-link" href="https://www.ncbi.nlm.nih.gov/pmc/advanced/" data-ga-action="featured_link" data-ga-label="advanced_search">
                            Advanced Search
                        </a>
                    </li>
                    <li>
                        
                            <a class="usa-link" href="/journals/" data-ga-action="featured_link" data-ga-label="journal list">
                                Journal List
                            </a>
                        
                    </li>
                    <li>
                        
                            <a class="usa-link" href="/about/userguide/" data-ga-action="featured_link"
                            data-ga-label="user guide">
                                User Guide
                            </a>
                        
                    </li>
                </ul>
                
                    <button form="pmc-search-form" formaction="https://pmc.ncbi.nlm.nih.gov/search/" type="submit" class="usa-button usa-button--unstyled hover:text-no-underline text-no-underline width-auto margin-top-1 tablet:margin-top-0">
     <span class="bg-green-label padding-05 text-white">New</span><span class="text-underline text-primary">Try this search in PMC Beta Search</span>
</button>
                
            </div>
        </div>
    </div>
</section>

    


        
        

       
  <div class="usa-section padding-top-0 desktop:padding-top-6 pmc-article-section" data-article-db="pmc" data-article-id="12198695">

    

   



<div class="grid-container pmc-actions-bar" aria-label="Actions bar" role="complementary">
    <div class="grid-row">
        <div class="grid-col-fill display-flex">
             <div class="display-flex">
                <ul class="usa-list usa-list--unstyled usa-list--horizontal">
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <button
                                type="button"
                                class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                                aria-label="Open resources"
                                data-extra-class="is-visible-resources"
                                data-ga-category="resources_accordion"
                                data-ga-action="click"
                                data-ga-label="mobile_icon"
                        >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#more_vert"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <a
                                href="https://doi.org/10.1002/npr2.70034"
                                class="usa-link display-flex usa-tooltip"
                                role="button"
                                target="_blank"
                                rel="noreferrer noopener"
                                title="View on publisher site"
                                data-position="bottom"
                                aria-label="View on publisher site"
                                data-ga-category="actions"
                                data-ga-action="click"
                                data-ga-label="publisher_link_mobile"
                        >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#launch"></use>
                                </svg>
                        </a>
                    </li>
                    
                    
                        <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                             <a
                                     href="pdf/NPR2-45-e70034.pdf"
                                     class="usa-link display-flex usa-tooltip"
                                     role="button"
                                     title="Download PDF"
                                     data-position="bottom"
                                     aria-label="Download PDF"
                                     data-ga-category="actions"
                                     data-ga-action="click"
                                     data-ga-label="pdf_download_mobile"
                             >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                                </svg>
                            </a>
                        </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button
                            class="usa-button usa-button--unstyled  usa-tooltip collections-dialog-trigger collections-button display-flex collections-button-empty"
                            title="Add to Collections"
                            data-position="bottom"
                            aria-label="Save article in MyNCBI collections."
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="collections_button_mobile"
                            data-collections-open-dialog-enabled="false"
                            data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12198695%2F%3Freport%3Dclassic%23open-collections-dialog"
                            data-in-collections="false"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button role="button" class="usa-button usa-button--unstyled usa-tooltip citation-dialog-trigger display-flex"
                            aria-label="Open dialog with citation text in different styles"
                            title="Cite"
                            data-position="bottom"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="cite_mobile"
                            data-all-citations-url="/resources/citations/12198695/"
                            data-citation-style="nlm"
                            data-download-format-link="/resources/citations/12198695/export/"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="pmc-permalink display-flex" >
                         <button
                                 type="button"
                                 title="Permalink"
                                 data-position="bottom"
                                 class="usa-button usa-button--unstyled display-flex usa-tooltip"
                                 aria-label="Show article permalink"
                                 aria-expanded="false"
                                 aria-haspopup="true"
                                 data-ga-category="actions"
                                 data-ga-action="open"
                                 data-ga-label="permalink_mobile"
                         >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#share"></use>
                            </svg>
                        </button>
                        

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12198695/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
                    </li>
                </ul>
            </div>
            <button
                    type="button"
                    class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                    aria-label="Open article navigation"
                    data-extra-class="is-visible-in-page"
                    data-ga-category="actions"
                    data-ga-action="open"
                    data-ga-label="article_nav_mobile"
            >
                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#list"></use>
                </svg>
            </button>
        </div>
    </div>
</div>
    <div class="grid-container desktop:padding-left-6">
      <div id="article-container" class="grid-row grid-gap">
        <div class="grid-col-12 desktop:grid-col-8 order-2 pmc-layout__content">
            <div class="grid-container padding-left-0 padding-right-0">
                <div class="grid-row desktop:margin-left-neg-6">
                    <div class="grid-col-12">
                        <div class="pmc-layout__disclaimer" role="complementary" aria-label="Disclaimer note">
    As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with,
    the contents by NLM or the National Institutes of Health.<br/>
    Learn more:
    <a class="usa-link" data-ga-category="Link click" data-ga-action="Disclaimer" data-ga-label="New disclaimer box" href="/about/disclaimer/">PMC Disclaimer</a>
    |
    <a class="usa-link" data-ga-category="Link click" data-ga-action="PMC Copyright Notice" data-ga-label="New disclaimer box" href="/about/copyright/">
        PMC Copyright Notice
    </a>
</div>
                    </div>
                </div>
                <div class="grid-row pmc-wm desktop:margin-left-neg-6">
                    <!-- Main content -->
                    <main
                      id="main-content"
                      class="usa-layout-docs__main usa-layout-docs grid-col-12 pmc-layout pmc-prose padding-0"
                    >

                      
                        <section class="pmc-journal-banner text-center line-height-none" aria-label="Journal banner"><img src="https://cdn.ncbi.nlm.nih.gov/pmc/banners/logo-neurorep.jpg" alt="Neuropsychopharmacology Reports logo" usemap="#pmc-banner-imagemap" width="500" height="75"><map name="pmc-banner-imagemap"><area alt="Link to Neuropsychopharmacology Reports" title="Link to Neuropsychopharmacology Reports" shape="default" href="https://onlinelibrary.wiley.com/journal/2574173x" target="_blank" rel="noopener noreferrer"></map></section><article lang="en"><section aria-label="Article citation and metadata"><section class="pmc-layout__citation font-secondary font-xs"><div>
<div class="display-inline-block"><button type="button" class="cursor-pointer text-no-underline bg-transparent border-0 padding-0 text-left margin-0 text-normal text-primary" aria-controls="journal_context_menu">Neuropsychopharmacol Rep</button></div>. 2025 Jun 26;45(3):e70034. doi: <a href="https://doi.org/10.1002/npr2.70034" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">10.1002/npr2.70034</a>
</div>
<nav id="journal_context_menu" hidden="hidden"><ul class="menu-list font-family-ui" role="menu">
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/pmc/?term=%22Neuropsychopharmacol%20Rep%22%5Bjour%5D" class="usa-link" role="menuitem">Search in PMC</a></li>
<li role="presentation"><a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Neuropsychopharmacol%20Rep%22%5Bjour%5D" lang="en" class="usa-link" role="menuitem">Search in PubMed</a></li>
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/nlmcatalog?term=%22Neuropsychopharmacol%20Rep%22%5BTitle%20Abbreviation%5D" class="usa-link" role="menuitem">View in NLM Catalog</a></li>
<li role="presentation"><a href="?term=%22Neuropsychopharmacol%20Rep%22%5Bjour%5D" class="usa-link" role="menuitem" data-add-to-search="true">Add to search</a></li>
</ul></nav></section><section class="front-matter"><div class="ameta p font-secondary font-xs">
<hgroup><h1>Efficacy and Safety of Histamine H3 Receptor Antagonist/Inverse Agonist Including Betahistine for Schizophrenia: A Systematic Review and Meta‐Analysis</h1></hgroup><div class="cg p">
<a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Nishii%20Y%22%5BAuthor%5D" class="usa-link" aria-describedby="id1"><span class="name western">Yasufumi Nishii</span></a><div hidden="hidden" id="id1">
<h3><span class="name western">Yasufumi Nishii</span></h3>
<div class="p">
<sup>
<sup>1</sup>
</sup>Department of Psychiatry, Fujita Health University School of Medicine, Toyoake, Aichi, Japan</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Nishii%20Y%22%5BAuthor%5D" class="usa-link"><span class="name western">Yasufumi Nishii</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Sakuma%20K%22%5BAuthor%5D" class="usa-link" aria-describedby="id2"><span class="name western">Kenji Sakuma</span></a><div hidden="hidden" id="id2">
<h3><span class="name western">Kenji Sakuma</span></h3>
<div class="p">
<sup>
<sup>1</sup>
</sup>Department of Psychiatry, Fujita Health University School of Medicine, Toyoake, Aichi, Japan</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Sakuma%20K%22%5BAuthor%5D" class="usa-link"><span class="name western">Kenji Sakuma</span></a>
</div>
</div>
<sup>1,</sup><sup>✉</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Hamanaka%20S%22%5BAuthor%5D" class="usa-link" aria-describedby="id3"><span class="name western">Shun Hamanaka</span></a><div hidden="hidden" id="id3">
<h3><span class="name western">Shun Hamanaka</span></h3>
<div class="p">
<sup>
<sup>1</sup>
</sup>Department of Psychiatry, Fujita Health University School of Medicine, Toyoake, Aichi, Japan</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Hamanaka%20S%22%5BAuthor%5D" class="usa-link"><span class="name western">Shun Hamanaka</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Iwata%20N%22%5BAuthor%5D" class="usa-link" aria-describedby="id4"><span class="name western">Nakao Iwata</span></a><div hidden="hidden" id="id4">
<h3><span class="name western">Nakao Iwata</span></h3>
<div class="p">
<sup>
<sup>1</sup>
</sup>Department of Psychiatry, Fujita Health University School of Medicine, Toyoake, Aichi, Japan</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Iwata%20N%22%5BAuthor%5D" class="usa-link"><span class="name western">Nakao Iwata</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Kishi%20T%22%5BAuthor%5D" class="usa-link" aria-describedby="id5"><span class="name western">Taro Kishi</span></a><div hidden="hidden" id="id5">
<h3><span class="name western">Taro Kishi</span></h3>
<div class="p">
<sup>
<sup>1</sup>
</sup>Department of Psychiatry, Fujita Health University School of Medicine, Toyoake, Aichi, Japan</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Kishi%20T%22%5BAuthor%5D" class="usa-link"><span class="name western">Taro Kishi</span></a>
</div>
</div>
<sup>1,</sup><sup>✉</sup>
</div>
<ul class="d-buttons inline-list">
<li><button class="d-button" aria-controls="aip_a" aria-expanded="false">Author information</button></li>
<li><button class="d-button" aria-controls="anp_a" aria-expanded="false">Article notes</button></li>
<li><button class="d-button" aria-controls="clp_a" aria-expanded="false">Copyright and License information</button></li>
</ul>
<div class="d-panels font-secondary-light">
<div id="aip_a" class="d-panel p" style="display: none">
<div class="p" id="npr270034-aff-0001">
<sup>
<sup>1</sup>
</sup>Department of Psychiatry, Fujita Health University School of Medicine, Toyoake, Aichi, Japan</div>
<div class="author-notes p">
<div class="fn" id="correspondenceTo">
<sup>*</sup><p class="display-inline">

<strong>Correspondence:</strong>
 
Taro Kishi (<span>tarok@fujita-hu.ac.jp</span>), 
Kenji Sakuma (<span>sakuma44@fujita-hu.ac.jp</span>)
</p>
</div>
<div class="fn" id="_fncrsp93pmc__">
<sup>✉</sup><p class="display-inline">Corresponding author.</p>
</div>
</div>
</div>
<div id="anp_a" class="d-panel p" style="display: none"><div class="notes p"><section id="historyarticle-meta1" class="history"><p>Revised 2025 Apr 4; Received 2025 Jan 25; Accepted 2025 Jun 7; Collection date 2025 Sep.</p></section></div></div>
<div id="clp_a" class="d-panel p" style="display: none">
<div>© 2025 The Author(s). <em>Neuropsychopharmacology Reports</em> published by John Wiley &amp; Sons Australia, Ltd on behalf of The Japanese Society of Neuropsychopharmacology.</div>
<p>This is an open access article under the terms of the <a href="https://creativecommons.org/licenses/by/4.0/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">http://creativecommons.org/licenses/by/4.0/</a> License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.</p>
<div class="p"><a href="/about/copyright/" class="usa-link">PMC Copyright notice</a></div>
</div>
</div>
<div>PMCID: PMC12198695  PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/40567153/" class="usa-link">40567153</a>
</div>
</div></section></section><section aria-label="Article content"><section class="body main-article-body"><section class="abstract" id="abstract1"><h2>ABSTRACT</h2>
<section id="npr270034-sec-0001"><h3 class="pmc_sec_title">Aim</h3>
<p>Whether histamine H3 receptor antagonists (H3R‐ANTs)/inverse agonists (H3R‐IAs) provides benefit for the treatment of schizophrenia remains unclear. This meta‐analysis was conducted to address the above clinical question.</p></section><section id="npr270034-sec-0002"><h3 class="pmc_sec_title">Methods</h3>
<p>Cognitive Function Scale's composite score (primary), seven domains of cognitive function (speed of processing, attention/vigilance, working memory, verbal learning, visual learning, reasoning/problem solving, and social cognition) score, University of California San Diego Performance‐Based Skills Assessment score, psychopathology scales score, discontinuation rate, and incidence of individual adverse events were among the study outcomes. The standardized mean differences (SMD) or risk ratios (RR) with 95% confidence intervals (CIs) were calculated.</p></section><section id="npr270034-sec-0003"><h3 class="pmc_sec_title">Results</h3>
<p>Our meta‐analysis included 11 double‐blind, randomized, placebo‐controlled trials (<em>n</em> = 754). Our study evaluated ABT‐288, betahistine, betahistine+reboxetine, GSK239512, MK‐0249, and pitolisant. Betahistine has an H1‐receptor agonistic reaction and H3‐receptor antagonistic reaction, while other drugs only have an H3‐receptor antagonistic/inverse agonistic reaction. Hence, we conducted a meta‐analysis for all outcomes divided by betahistine or other pooled H3R‐ANTs/H3R‐IAs. The study results show that betahistine outperformed placebo in the improvement of overall cognitive symptoms (SMD [95% CI] = −0.61 [−1.03, −0.18]), speed of processing (−0.44 [−0.87, −0.02]), attention/vigilance (−0.43 [−0.85, −0.01]), working memory (−0.48 [−0.90, −0.06]), verbal learning (−0.62 [−1.04, −0.19]), visual learning (−0.57 [−1.00, −0.15]), and betahistine+reboxetine was superior in the improvement of depressive symptoms (−4.04 [−5.10, −2.97]). Pitolisant outperformed placebo in depressive symptom improvement (−3.24 [−4.22, −2.26]). However, the results were derived from one betahistine, betahistine+reboxetine, or pitolisant study. Other pooled H3R‐ANTs/H3R‐IAs revealed risk of insomnia (RR [95% CI] = 2.18 [1.05, 4.55]). However, no differences were observed in other any outcomes between betahistine or other pooled H3R‐ANTs/H3R‐IAs and placebo.</p></section><section id="npr270034-sec-0004"><h3 class="pmc_sec_title">Conclusions</h3>
<p>Some H3R‐ANTs/H3R‐IAs might provide benefit for the treatment of cognitive symptoms and depressive symptoms in individuals afflicted with schizophrenia.</p></section><section id="kwd-group1" class="kwd-group"><p><strong>Keywords:</strong> betahistine, histamine H3 receptor antagonist or inverse agonist, pitolisant, schizophrenia, systematic review and meta‐analysis</p></section></section><section class="abstract" id="d68e191"><hr class="headless">
<section class="bt xbox font-sm" id="npr270034-blkfxd-0001"><p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><img class="graphic" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/939e/12198695/cbd1af9fd20b/NPR2-45-e70034-g002.jpg" loading="lazy" id="jats-graphic-1" height="184" width="331" alt="graphic file with name NPR2-45-e70034-g002.jpg"></p></section></section><section id="npr270034-sec-0005"><h2 class="pmc_sec_title">1. Introduction</h2>
<p>One of the common mental illnesses with a lifetime prevalence of approximately 1% is schizophrenia [<a href="#npr270034-bib-0001" class="usa-link" aria-describedby="npr270034-bib-0001">1</a>]. Symptoms of schizophrenia are classified as positive, negative, and cognitive symptoms [<a href="#npr270034-bib-0002" class="usa-link" aria-describedby="npr270034-bib-0002">2</a>]. Antipsychotic pharmacotherapy is the primary treatment for schizophrenia, and its efficacy in treating psychopathologies is relatively well established, particularly regarding positive and negative symptoms [<a href="#npr270034-bib-0003" class="usa-link" aria-describedby="npr270034-bib-0003">3</a>]. The study analyzed recent data; the US economic burden estimate for schizophrenia reported that excess indirect costs (unemployment, productivity loss, premature mortality, and caregiving) accounted for 73.4% ($251.9 billion) of the total economic burden of schizophrenia [<a href="#npr270034-bib-0004" class="usa-link" aria-describedby="npr270034-bib-0004">4</a>]. The indirect costs might be associated with cognitive impairments [<a href="#npr270034-bib-0004" class="usa-link" aria-describedby="npr270034-bib-0004">4</a>]. However, antipsychotics fail to effectively address cognitive impairments [<a href="#npr270034-bib-0005" class="usa-link" aria-describedby="npr270034-bib-0005">5</a>]. Although our meta‐analysis showed that memantine might have benefits for the improvement of cognitive symptoms in schizophrenia, the evidence level was low [<a href="#npr270034-bib-0006" class="usa-link" aria-describedby="npr270034-bib-0006">6</a>]. Thus, only antipsychotic treatments are often considered insufficient to enhance the patients' quality of life, as most individuals tend to have a chronic course owing to various residual schizophrenia symptoms, particularly cognitive symptoms [<a href="#npr270034-bib-0007" class="usa-link" aria-describedby="npr270034-bib-0007">7</a>]. Hence, the development of novel treatments underscoring improving cognitive symptoms is a pressing issue in schizophrenia research.</p>
<p>Recently, histamine H3 receptor antagonists (H3R‐ANTs) or inverse agonists (H3R‐IAs) have been proposed as novel treatments for schizophrenia. A radioligand binding study of the brain found remarkable increases in H3 receptor binding in patients with schizophrenia compared with normal controls, indicating that the increased H3 receptors in the prefrontal cortex may be implicated in cognition impairment [<a href="#npr270034-bib-0008" class="usa-link" aria-describedby="npr270034-bib-0008">8</a>]. H3R‐ANTs/H3R‐IAs increase the synaptic release of histamine and other neurotransmitters, including acetylcholine and glutamate [<a href="#npr270034-bib-0009" class="usa-link" aria-describedby="npr270034-bib-0009">9</a>], thereby improving synaptoplastic processes linked to memory [<a href="#npr270034-bib-0010" class="usa-link" aria-describedby="npr270034-bib-0010">10</a>]. Recent animal studies reported that H3R‐ANT‐induced neurotransmitter release leads to postsynaptic receptor pathway activation, such as phosphorylation of cyclic adenosine monophosphate response element binding protein, a transcription factor germane to cognitive function [<a href="#npr270034-bib-0011" class="usa-link" aria-describedby="npr270034-bib-0011">11</a>]. Thus, H3R‐ANTs/H3R‐IAs may improve cognitive decline in individuals with schizophrenia [<a href="#npr270034-bib-0010" class="usa-link" aria-describedby="npr270034-bib-0010">10</a>, <a href="#npr270034-bib-0011" class="usa-link" aria-describedby="npr270034-bib-0011">11</a>].</p>
<p>To date, 11 double‐blind, randomized, placebo‐controlled trials (DBRPCTs) on H3R‐ANTs/H3R‐IAs (ABT‐288, betahistine, GSK239512, MK‐0249, and pitolisant) for individuals with schizophrenia have been conducted (Table <a href="#npr270034-tbl-0001" class="usa-link">1</a>) [<a href="#npr270034-bib-0013" class="usa-link" aria-describedby="npr270034-bib-0013">13</a>, <a href="#npr270034-bib-0014" class="usa-link" aria-describedby="npr270034-bib-0014">14</a>, <a href="#npr270034-bib-0015" class="usa-link" aria-describedby="npr270034-bib-0015">15</a>, <a href="#npr270034-bib-0016" class="usa-link" aria-describedby="npr270034-bib-0016">16</a>, <a href="#npr270034-bib-0017" class="usa-link" aria-describedby="npr270034-bib-0017">17</a>, <a href="#npr270034-bib-0018" class="usa-link" aria-describedby="npr270034-bib-0018">18</a>, <a href="#npr270034-bib-0019" class="usa-link" aria-describedby="npr270034-bib-0019">19</a>, <a href="#npr270034-bib-0020" class="usa-link" aria-describedby="npr270034-bib-0020">20</a>, <a href="#npr270034-bib-0021" class="usa-link" aria-describedby="npr270034-bib-0021">21</a>, <a href="#npr270034-bib-0022" class="usa-link" aria-describedby="npr270034-bib-0022">22</a>]. One DBRPCT showed that betahistine, which is an H1‐receptor agonist and H3R‐ANT [<a href="#npr270034-bib-0021" class="usa-link" aria-describedby="npr270034-bib-0021">21</a>], improved the Measurement and Treatment Research to Improve Cognition in Schizophrenia Consensus Cognitive Battery (MCCB) composite score and some domain scores of the MCCB [<a href="#npr270034-bib-0023" class="usa-link" aria-describedby="npr270034-bib-0023">23</a>] compared with placebo [<a href="#npr270034-bib-0018" class="usa-link" aria-describedby="npr270034-bib-0018">18</a>]; however, other trials failed to demonstrate the superiority of H3R‐ANTs/H3R‐IAs over placebo in the efficacy outcomes for individuals with schizophrenia (Table <a href="#npr270034-tbl-0001" class="usa-link">1</a>). These discrepant results may be secondary to the small sample sizes of these trials (Table <a href="#npr270034-tbl-0001" class="usa-link">1</a>) [<a href="#npr270034-bib-0024" class="usa-link" aria-describedby="npr270034-bib-0024">24</a>]. The meta‐analysis can overcome the limitation of sample size in underpowered studies as a meta‐analysis can increase the statistical power for group comparisons [<a href="#npr270034-bib-0025" class="usa-link" aria-describedby="npr270034-bib-0025">25</a>]. Hence, a systematic review and meta‐analysis of DBRPCTs of H3R‐ANTs/H3R‐IAs for schizophrenia with respect to the efficacy, acceptability, tolerability, and safety outcomes was conducted.</p>
<section class="tw xbox font-sm" id="npr270034-tbl-0001"><h3 class="obj_head">TABLE 1.</h3>
<div class="caption p"><p>Study characteristics of the included double‐blind randomized placebo‐controlled trials in our systematic review and meta‐analysis.</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<col align="left" span="1">
<col align="center" span="1">
<col align="center" span="1">
<col align="center" span="1">
<col align="center" span="1">
<col align="center" span="1">
<col align="center" span="1">
<col align="center" span="1">
<col align="center" span="1">
<col align="center" span="1">
<thead valign="bottom">
<tr style="border-bottom:solid 1px #000000">
<th align="left" rowspan="2" valign="bottom" colspan="1">(1) Study name, (2) Total <em>n</em>, (3) Country, (4) Sponsorship</th>
<th align="center" rowspan="2" valign="bottom" colspan="1">Study duration (w)</th>
<th align="center" rowspan="2" valign="bottom" colspan="1">(1) Diagnosis, (2) Status</th>
<th align="center" rowspan="2" valign="bottom" colspan="1">Intervention (dose, mg/d)</th>
<th align="center" rowspan="2" valign="bottom" colspan="1">
<em>n</em>
</th>
<th align="center" rowspan="2" valign="bottom" colspan="1">(1) Age (mean ± SD, y), (2) Female (%), (3) Race/ethnicity (%)</th>
<th align="center" rowspan="2" valign="bottom" colspan="1">(1) AP (%), (2) Mean AP dose (CHL eq (mg/d)<a href="#npr270034-note-0003" class="usa-link">
<sup>a</sup>
</a>)</th>
<th align="center" rowspan="2" valign="bottom" colspan="1">SZ symptoms at BL (mean ± SD)</th>
<th align="center" colspan="2" valign="bottom" rowspan="1">CS of cognitive tests</th>
</tr>
<tr style="border-bottom:solid 1px #000000">
<th align="center" valign="bottom" rowspan="1" colspan="1">At baseline (mean ± SD)</th>
<th align="center" valign="bottom" rowspan="1" colspan="1">Result<a href="#npr270034-note-0004" class="usa-link">
<sup>b</sup>
</a>
</th>
</tr>
</thead>
<tbody valign="top">
<tr><td align="left" colspan="10" valign="top" rowspan="1">
<em>Histamine H3 antagonist studies</em>
</td></tr>
<tr>
<td align="left" rowspan="3" valign="top" colspan="1">(1) Haig 2014, (2) 214, (3) USA, (4) Industry</td>
<td align="center" rowspan="3" valign="top" colspan="1">12</td>
<td align="center" rowspan="3" valign="top" colspan="1">(1) Stable SZ (DSM‐IV‐TR), (2) OP</td>
<td align="center" valign="top" rowspan="1" colspan="1">ABT‐288 (10)</td>
<td align="center" valign="top" rowspan="1" colspan="1">72</td>
<td align="center" rowspan="3" valign="top" colspan="1">(1) 43.1 ± 9.5, (2) 33.8, (3) White: 37.1</td>
<td align="center" rowspan="3" valign="top" colspan="1">(1) SGAs (100.0), (2) NR</td>
<td align="center" rowspan="3" valign="top" colspan="1">PANSS‐T: 64.4 ± 11.9</td>
<td align="center" rowspan="3" valign="top" colspan="1">MCCB: 28.1 ± 11.9</td>
<td align="center" rowspan="3" valign="top" colspan="1">ABT‐288 = PLA</td>
</tr>
<tr>
<td align="center" valign="top" rowspan="1" colspan="1">ABT‐288 (25)</td>
<td align="center" valign="top" rowspan="1" colspan="1">70</td>
</tr>
<tr>
<td align="center" valign="top" rowspan="1" colspan="1">PLA</td>
<td align="center" valign="top" rowspan="1" colspan="1">72</td>
</tr>
<tr>
<td align="left" rowspan="11" valign="top" colspan="1">(1) Othman 2014<a href="#npr270034-note-0005" class="usa-link">
<sup>c</sup>
</a>, (2) 67, (3) USA, (4) Industry</td>
<td align="center" rowspan="11" valign="top" colspan="1">2</td>
<td align="center" rowspan="11" valign="top" colspan="1">(1) Stable SZ (DSM‐IV‐TR), (2) OP</td>
<td align="center" valign="top" rowspan="1" colspan="1">ABT‐288 (1)</td>
<td align="center" valign="top" rowspan="1" colspan="1">NR</td>
<td align="center" rowspan="11" valign="top" colspan="1">(1) 42.0 ± 9.0, (2) 22.4, (3) White: 23.9</td>
<td align="center" rowspan="11" valign="top" colspan="1">(1) SGAs (100.0), (2) NR</td>
<td align="center" rowspan="11" valign="top" colspan="1">NR</td>
<td align="center" rowspan="11" valign="top" colspan="1">NR</td>
<td align="center" rowspan="11" valign="top" colspan="1">NR</td>
</tr>
<tr>
<td align="center" valign="top" rowspan="1" colspan="1">ABT‐288 (3)</td>
<td align="center" valign="top" rowspan="1" colspan="1">NR</td>
</tr>
<tr>
<td align="center" valign="top" rowspan="1" colspan="1">ABT‐288 (6)</td>
<td align="center" valign="top" rowspan="1" colspan="1">NR</td>
</tr>
<tr>
<td align="center" valign="top" rowspan="1" colspan="1">ABT‐288 (9)</td>
<td align="center" valign="top" rowspan="1" colspan="1">NR</td>
</tr>
<tr>
<td align="center" valign="top" rowspan="1" colspan="1">ABT‐288 (12)</td>
<td align="center" valign="top" rowspan="1" colspan="1">NR</td>
</tr>
<tr>
<td align="center" valign="top" rowspan="1" colspan="1">ABT‐288 (15)</td>
<td align="center" valign="top" rowspan="1" colspan="1">NR</td>
</tr>
<tr>
<td align="center" valign="top" rowspan="1" colspan="1">ABT‐288 (20)</td>
<td align="center" valign="top" rowspan="1" colspan="1">NR</td>
</tr>
<tr>
<td align="center" valign="top" rowspan="1" colspan="1">ABT‐288 (30)</td>
<td align="center" valign="top" rowspan="1" colspan="1">NR</td>
</tr>
<tr>
<td align="center" valign="top" rowspan="1" colspan="1">ABT‐288 (45)</td>
<td align="center" valign="top" rowspan="1" colspan="1">NR</td>
</tr>
<tr>
<td align="center" valign="top" rowspan="1" colspan="1">ABT‐288 (60)</td>
<td align="center" valign="top" rowspan="1" colspan="1">NR</td>
</tr>
<tr>
<td align="center" valign="top" rowspan="1" colspan="1">PLA</td>
<td align="center" valign="top" rowspan="1" colspan="1">NR</td>
</tr>
<tr>
<td align="left" rowspan="2" valign="top" colspan="1">(1) Jarskog 2015, (2) 50, (3) USA, (4) Industry</td>
<td align="center" rowspan="2" valign="top" colspan="1">7</td>
<td align="center" rowspan="2" valign="top" colspan="1">(1) Stable SZ (DSM‐IV‐TR), (2) OP</td>
<td align="center" valign="top" rowspan="1" colspan="1">GSK239512 (0.08)</td>
<td align="center" valign="top" rowspan="1" colspan="1">25</td>
<td align="center" rowspan="2" valign="top" colspan="1">(1) 39.2 ± 11.2, (2) 21.7, (3) White: 45.7</td>
<td align="center" rowspan="2" valign="top" colspan="1">(1) SGAs and/or FGAs (100.0), (2) NR</td>
<td align="center" rowspan="2" valign="top" colspan="1">BPRS‐T: 29.7 ± 6.6</td>
<td align="center" rowspan="2" valign="top" colspan="1">MCCB: 31.6 ± 12.1</td>
<td align="center" rowspan="2" valign="top" colspan="1">GSK239512 = PLA</td>
</tr>
<tr>
<td align="center" valign="top" rowspan="1" colspan="1">PLA</td>
<td align="center" valign="top" rowspan="1" colspan="1">25</td>
</tr>
<tr><td align="left" colspan="10" valign="top" rowspan="1">
<em>Histamine H3 inverse agonist study</em>
</td></tr>
<tr>
<td align="left" rowspan="2" valign="top" colspan="1">(1) Egan 2013<a href="#npr270034-note-0006" class="usa-link">
<sup>d</sup>
</a>, (2) 55, (3) Russia and India, (4) Industry</td>
<td align="center" rowspan="2" valign="top" colspan="1">4</td>
<td align="center" rowspan="2" valign="top" colspan="1">(1) Stable SZ (DSM‐IV or DSM‐IV‐TR), (2) OP</td>
<td align="center" valign="top" rowspan="1" colspan="1">MK‐0249 (10)</td>
<td align="center" valign="top" rowspan="1" colspan="1">28</td>
<td align="center" rowspan="2" valign="top" colspan="1">(1) 31.6 ± 7.9, (2) 27.3, (3) White: 63.6</td>
<td align="center" rowspan="2" valign="top" colspan="1">(1) SGAs and/or FGAs (100.0), (2) NR (= &lt; 1000)</td>
<td align="center" rowspan="2" valign="top" colspan="1">PANSS‐T: 56.0 ± 9.1</td>
<td align="center" rowspan="2" valign="top" colspan="1">BACS: 41.7 ± 8.9</td>
<td align="center" rowspan="2" valign="top" colspan="1">MK‐0249 = PLA</td>
</tr>
<tr>
<td align="center" valign="top" rowspan="1" colspan="1">PLA</td>
<td align="center" valign="top" rowspan="1" colspan="1">27</td>
</tr>
<tr><td align="left" colspan="10" valign="top" rowspan="1">
<em>Histamine H3 antagonist/inverse agonist study</em>
</td></tr>
<tr>
<td align="left" rowspan="2" valign="top" colspan="1">(1) <a href="https://clinicaltrials.gov/ct2/show/NCT00690274" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NCT00690274</a> 2019<a href="#npr270034-note-0007" class="usa-link">
<sup>e</sup>
</a>, (2) 52, (3) USA, (4) Academia</td>
<td align="center" rowspan="2" valign="top" colspan="1">12</td>
<td align="center" rowspan="2" valign="top" colspan="1">(1) Stable SZ or SA (DSM‐IV), (2) NR</td>
<td align="center" valign="top" rowspan="1" colspan="1">PIT (20)</td>
<td align="center" valign="top" rowspan="1" colspan="1">23</td>
<td align="center" rowspan="2" valign="top" colspan="1">(1) NR, (2) 76.3, (3) White: 73.7</td>
<td align="center" rowspan="2" valign="top" colspan="1">(1) APs (100.0), (2) NR</td>
<td align="center" rowspan="2" valign="top" colspan="1">NR</td>
<td align="center" rowspan="2" valign="top" colspan="1">NR</td>
<td align="center" rowspan="2" valign="top" colspan="1">NR</td>
</tr>
<tr>
<td align="center" valign="top" rowspan="1" colspan="1">PLA</td>
<td align="center" valign="top" rowspan="1" colspan="1">29</td>
</tr>
<tr><td align="left" colspan="10" valign="top" rowspan="1">
<em>BET studies</em>
</td></tr>
<tr>
<td align="left" rowspan="2" valign="top" colspan="1">(1) Bai 2023, (2) 94, (3) China, (4) Academia</td>
<td align="center" rowspan="2" valign="top" colspan="1">4</td>
<td align="center" rowspan="2" valign="top" colspan="1">(1) Stable SZ (ICD‐10), (2) IP</td>
<td align="center" valign="top" rowspan="1" colspan="1">BET (48)</td>
<td align="center" valign="top" rowspan="1" colspan="1">47</td>
<td align="center" rowspan="2" valign="top" colspan="1">(1) 46.4 ± 9.6, (2) 39.4, (3) Chinese (100.0)</td>
<td align="center" rowspan="2" valign="top" colspan="1">(1) SGAs (100.0), (2) NR (364.9)</td>
<td align="center" rowspan="2" valign="top" colspan="1">PANSS‐T: 74.7 ± 13.8</td>
<td align="center" rowspan="2" valign="top" colspan="1">NR</td>
<td align="center" rowspan="2" valign="top" colspan="1">NR</td>
</tr>
<tr>
<td align="center" valign="top" rowspan="1" colspan="1">PLA</td>
<td align="center" valign="top" rowspan="1" colspan="1">47</td>
</tr>
<tr>
<td align="left" rowspan="2" valign="top" colspan="1">(1) Barak 2016, (2) 36, (3) Canada and Israel, (4) Industry</td>
<td align="center" rowspan="2" valign="top" colspan="1">16</td>
<td align="center" rowspan="2" valign="top" colspan="1">(1) SZ, SA, SF, or PD‐NOS (DSM‐IV), (2) NR</td>
<td align="center" valign="top" rowspan="1" colspan="1">BET (48)</td>
<td align="center" valign="top" rowspan="1" colspan="1">NR</td>
<td align="center" rowspan="2" valign="top" colspan="1">(1) 26.6 (both adolescents and adults), (2) 28.6, (3) White: 97.1</td>
<td align="center" rowspan="2" valign="top" colspan="1">(1) OLA (100.0), (2) 12.0 (360.0)</td>
<td align="center" rowspan="2" valign="top" colspan="1">NR</td>
<td align="center" rowspan="2" valign="top" colspan="1">NR</td>
<td align="center" rowspan="2" valign="top" colspan="1">NR</td>
</tr>
<tr>
<td align="center" valign="top" rowspan="1" colspan="1">PLA</td>
<td align="center" valign="top" rowspan="1" colspan="1">NR</td>
</tr>
<tr>
<td align="left" rowspan="2" valign="top" colspan="1">(1) Smith 2018a, (2) 40, (3) USA, (4) Academia</td>
<td align="center" rowspan="2" valign="top" colspan="1">12</td>
<td align="center" rowspan="2" valign="top" colspan="1">(1) SZ, SA, SF, or PD‐NOS, ASD, BD (NR), (2) IP or OP</td>
<td align="center" valign="top" rowspan="1" colspan="1">BET (48)</td>
<td align="center" valign="top" rowspan="1" colspan="1">19</td>
<td align="center" rowspan="2" valign="top" colspan="1">(1) 31.1 ± 14.2 (both adolescents and adults), (2) 59.0, (3) White: 33.3</td>
<td align="center" rowspan="2" valign="top" colspan="1">(1) SGAs including CLO and/or FGAs (100.0), (2) NR</td>
<td align="center" rowspan="2" valign="top" colspan="1">BPRS‐T: 32.8 ± 6.7</td>
<td align="center" rowspan="2" valign="top" colspan="1">NR</td>
<td align="center" rowspan="2" valign="top" colspan="1">NR</td>
</tr>
<tr>
<td align="center" valign="top" rowspan="1" colspan="1">PLA</td>
<td align="center" valign="top" rowspan="1" colspan="1">21</td>
</tr>
<tr>
<td align="left" rowspan="2" valign="top" colspan="1">(1) Smith 2018b, (2) 14, (3) China, (4) Academia</td>
<td align="center" rowspan="2" valign="top" colspan="1">12</td>
<td align="center" rowspan="2" valign="top" colspan="1">(1) SZ, SA, SF, or PD‐NOS, ASD, BD (NR), (2) IP or OP</td>
<td align="center" valign="top" rowspan="1" colspan="1">BET (36)</td>
<td align="center" valign="top" rowspan="1" colspan="1">10</td>
<td align="center" rowspan="2" valign="top" colspan="1">(1) NR, (2) NR, (3) NR</td>
<td align="center" rowspan="2" valign="top" colspan="1">(1) SGAs including CLO and/or FGAs (100.0), (2) NR</td>
<td align="center" rowspan="2" valign="top" colspan="1">NR</td>
<td align="center" rowspan="2" valign="top" colspan="1">NR</td>
<td align="center" rowspan="2" valign="top" colspan="1">NR</td>
</tr>
<tr>
<td align="center" valign="top" rowspan="1" colspan="1">PLA</td>
<td align="center" valign="top" rowspan="1" colspan="1">4</td>
</tr>
<tr>
<td align="left" rowspan="2" valign="top" colspan="1">(1) Wang 2021, (2) 89, (3) China, (4) Academia</td>
<td align="center" rowspan="2" valign="top" colspan="1">12</td>
<td align="center" rowspan="2" valign="top" colspan="1">(1) Stable SZ (ICD‐10), (2) IP</td>
<td align="center" valign="top" rowspan="1" colspan="1">BET (72)</td>
<td align="center" valign="top" rowspan="1" colspan="1">45</td>
<td align="center" rowspan="2" valign="top" colspan="1">(1) 47.2 ± 8.9, (2) 39.3, (3) Chinese: 100.0</td>
<td align="center" rowspan="2" valign="top" colspan="1">(1) SGAs (100.0), (2) NR (327.3)</td>
<td align="center" rowspan="2" valign="top" colspan="1">PANSS‐T: 73.2 ± 12.5</td>
<td align="center" rowspan="2" valign="top" colspan="1">MCCB: 39.3 ± 12.2</td>
<td align="center" rowspan="2" valign="top" colspan="1">BET &gt; PLA</td>
</tr>
<tr>
<td align="center" valign="top" rowspan="1" colspan="1">PLA</td>
<td align="center" valign="top" rowspan="1" colspan="1">44</td>
</tr>
<tr>
<td align="left" rowspan="2" valign="top" colspan="1">(1) Poyurovsky 2013, (2) 43, (3) Israel, (4) Academia</td>
<td align="center" rowspan="2" valign="top" colspan="1">6</td>
<td align="center" rowspan="2" valign="top" colspan="1">(1) First‐episode, drug‐naive SZ or SF (DSM‐IV), (2) IP</td>
<td align="center" valign="top" rowspan="1" colspan="1">BET (144) + REB (8)</td>
<td align="center" valign="top" rowspan="1" colspan="1">29</td>
<td align="center" rowspan="2" valign="top" colspan="1">(1) 32.5 ± 9.2, (2) 18.6, (3) NR</td>
<td align="center" rowspan="2" valign="top" colspan="1">(1) OLA (100.0), (2) 10.0 (300.0)</td>
<td align="center" rowspan="2" valign="top" colspan="1">NR</td>
<td align="center" rowspan="2" valign="top" colspan="1">NR</td>
<td align="center" rowspan="2" valign="top" colspan="1">NR</td>
</tr>
<tr>
<td align="center" valign="top" rowspan="1" colspan="1">PLA</td>
<td align="center" valign="top" rowspan="1" colspan="1">14</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/npr270034-tbl-0001/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p">
<div class="fn" id="npr270034-note-0002"><p>Abbreviations: AP, antipsychotic; ASD, autism spectrum disorder; BACS, Brief Assessment of Cognition in Schizophrenia; BD, bipolar disorder; BET, betahistine; BPRS‐T, Brief Psychiatric Rating Scale‐total score; CHL eq, chlorpromazine equivalent; CS, composite score; d, day; DBRPCT, double‐blind randomized placebo‐controlled trial; DSM, Diagnostic and Statistical Manual of Mental Disorders; FGA, first‐generation antipsychotic; ICD, International Classification of Diseases; IP, inpatient; MCCB, Measurement and Treatment Research to Improve Cognition in Schizophrenia Consensus Cognitive Battery; <em>n</em>, number of individuals; NR, not report; OLA, olanzapine; OP, outpatient; PANSS‐T, Positive and Negative Syndrome Scale total score; PD‐NOS, psychotic disorder not otherwise specified; PIT, pitolisant; PLA, placebo; REB, reboxetine; SA, schizoaffective disorder; SD, standard deviation; SF, schizophreniform disorder; SGA, second‐generation antipsychotic; SZ, schizophrenia; USA, United States of America; w, weeks; y, years.</p></div>
<div class="fn" id="npr270034-note-0003">
<sup>
<sup>a</sup>
</sup><p class="display-inline">We calculated the CHL eq based on the defined daily doses [<a href="#npr270034-bib-0012" class="usa-link" aria-describedby="npr270034-bib-0012">12</a>].</p>
</div>
<div class="fn" id="npr270034-note-0004">
<sup>
<sup>b</sup>
</sup><p class="display-inline">A &gt; B: A was superior to B. A = B: A was similar to B.</p>
</div>
<div class="fn" id="npr270034-note-0005">
<sup>
<sup>c</sup>
</sup><p class="display-inline">We did not include the Othman [<a href="#npr270034-bib-0013" class="usa-link" aria-describedby="npr270034-bib-0013">13</a>] study in our meta‐analysis as 21% of the participants were randomized twice.</p>
</div>
<div class="fn" id="npr270034-note-0006">
<sup>
<sup>d</sup>
</sup><p class="display-inline">Egan [<a href="#npr270034-bib-0014" class="usa-link" aria-describedby="npr270034-bib-0014">14</a>] study which was a crossover study did not report the first phase results (before crossover).</p>
</div>
<div class="fn" id="npr270034-note-0007">
<sup>
<sup>e</sup>
</sup><p class="display-inline">The year the study results were registered in <a href="http://clinicaltrials.gov" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">ClinicalTrials.gov</a>.</p>
</div>
</div></section></section><section id="npr270034-sec-0006"><h2 class="pmc_sec_title">2. Methods</h2>
<p>This systematic review and meta‐analysis was conducted following the Preferred Reporting Items for Systematic Reviews and Meta‐Analyses statement (Table <a href="#npr270034-supitem-0001" class="usa-link">S1</a>) [<a href="#npr270034-bib-0026" class="usa-link" aria-describedby="npr270034-bib-0026">26</a>]. This study was registered at the Open Science Framework (<a href="https://osf.io/s8ztv" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://osf.io/s8ztv</a>).</p>
<section id="npr270034-sec-0007"><h3 class="pmc_sec_title">2.1. Search Strategy, Inclusion Criteria, and Data Extraction</h3>
<p>Figure <a href="#npr270034-supitem-0001" class="usa-link">S1</a> summarizes the formal literature search and selection flow of H3R‐ANTs/H3R‐IA trials. At least two authors (Y.N., S.H., and K.S.) simultaneously and independently conducted the literature search and data extraction, and the obtained data were input into a spreadsheet for analysis. All data were evaluated for accuracy by at least two authors (Y.N., S.H., and K.S.). A formal systematic literature review was conducted using the Patient, Intervention, Comparison, and Outcome strategy. Only DBRPCTs of H3R‐ANTs/H3R‐IA were included.</p>
<p>Patient: Individuals with schizophrenia spectrum and other psychotic disorders who received antipsychotics.</p>
<p>Intervention: H3R‐ANT/H3R‐IAs (i.e., A‐349821, ABT‐239, ABT‐288, ABT‐652, APD‐916, AZD5213, betahistine, BF2.649, burimamide, CEP‐26401, ciproxifan, clobenpropit, conessine, GSK‐1004723, GSK‐189254, GSK‐239512, GSK‐835726, GW784568X, impentamine, iodophenpropit, irdabisant, JNJ‐17216498, JNJ‐31001074, JNJ‐39220675, JNJ‐5207852, LML‐134, MK‐0249, MK‐3134, MK‐7288, PF‐03654746, pitolisant, S 38093, SAR‐110894, SCH‐497079, SUVN‐G3031, thioperamide, triprolisant, and VUF5681) that were introduced as a H3R‐ANT/H3R‐IA in the following previous reviews [<a href="#npr270034-bib-0027" class="usa-link" aria-describedby="npr270034-bib-0027">27</a>, <a href="#npr270034-bib-0028" class="usa-link" aria-describedby="npr270034-bib-0028">28</a>, <a href="#npr270034-bib-0029" class="usa-link" aria-describedby="npr270034-bib-0029">29</a>].</p>
<p>Comparison: Placebo.</p>
<p>Outcomes: See the following section.</p>
<p>In the databases of Embase, PubMed, and the Cochrane Central Register of Controlled Trials, the authors searched for trials published before December 7, 2024. The detailed information regarding our literature search method was demonstrated in Figure <a href="#npr270034-supitem-0001" class="usa-link">S1</a>. The retrieved trials were assessed against the inclusion and exclusion criteria, and those eligible were selected. In the reference lists of the included trials and review articles, additional relevant published and unpublished trials, including conference abstracts, were manually searched. Clinical trial registries (e.g., <a href="http://clinicaltrials.gov" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">ClinicalTrials.gov</a> [<a href="http://clinicaltrials.gov/" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">http://clinicaltrials.gov/</a>] and the World Health Organization International Clinical Trials Registry Platform [<a href="http://www.who.int/ictrp/search/en/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">http://www.who.int/ictrp/search/en/</a>]) were also searched to ascertain that the eligible trials were comprehensive and to minimize the influence of publication bias. A consensus was achieved among the authors to resolve any discrepancies in the selected trials (Y.N., S.H., K.S., and T.K.).</p></section><section id="npr270034-sec-0008"><h3 class="pmc_sec_title">2.2. Outcome Measures and Data Synthesis</h3>
<p>The primary outcome was the cognitive function scale's composite score based on the MCCB and Brief Assessment of Cognition in Schizophrenia (BACS) [<a href="#npr270034-bib-0030" class="usa-link" aria-describedby="npr270034-bib-0030">30</a>] (Table <a href="#npr270034-supitem-0001" class="usa-link">S2</a>). Other outcomes included seven domain scores of cognitive function (speed of processing [only MCCB], attention/vigilance [only MCCB], working memory [MCCB and BACS + University of Pennsylvania Computerized Neuropsychological battery [<a href="#npr270034-bib-0031" class="usa-link" aria-describedby="npr270034-bib-0031">31</a>]], verbal learning [only MCCB], visual learning [MCCB and Brief Visuospatial Memory Test‐Revised [<a href="#npr270034-bib-0032" class="usa-link" aria-describedby="npr270034-bib-0032">32</a>]], reasoning/problem solving [only MCCB], and social cognition [only MCCB]), University of California San Diego Performance‐Based Skills Assessment (UPSA) [<a href="#npr270034-bib-0033" class="usa-link" aria-describedby="npr270034-bib-0033">33</a>] score, schizophrenia total symptom score based on the total scores for the Positive and Negative Syndrome Scale (PANSS) [<a href="#npr270034-bib-0034" class="usa-link" aria-describedby="npr270034-bib-0034">34</a>] and the Brief Psychiatric Rating Scale [<a href="#npr270034-bib-0035" class="usa-link" aria-describedby="npr270034-bib-0035">35</a>], positive symptom scores based on the scores for PANSS positive subscale and Scale for the Assessment of Positive Symptoms [<a href="#npr270034-bib-0036" class="usa-link" aria-describedby="npr270034-bib-0036">36</a>], negative symptom scores based on the scores for PANSS negative subscale, Scale for the Assessment of Negative Symptoms [<a href="#npr270034-bib-0037" class="usa-link" aria-describedby="npr270034-bib-0037">37</a>] and 16‐item Negative Symptom Assessment Scale [<a href="#npr270034-bib-0038" class="usa-link" aria-describedby="npr270034-bib-0038">38</a>], PANSS general subscale score, depressive symptom scale score based on the scores for Hamilton Depression Rating Scale [<a href="#npr270034-bib-0039" class="usa-link" aria-describedby="npr270034-bib-0039">39</a>] and Montgomery Åsberg Depression Rating Scale [<a href="#npr270034-bib-0040" class="usa-link" aria-describedby="npr270034-bib-0040">40</a>], Clinical Global Impressions‐Severity [<a href="#npr270034-bib-0041" class="usa-link" aria-describedby="npr270034-bib-0041">41</a>] score, all‐cause discontinuation rate, discontinuation rate due to adverse event, and incidence of individual adverse events (continuous variables: body mass index, body weight, waist circumference, hip circumference, serum triglyceride levels, low‐density lipoprotein cholesterol levels, and total cholesterol levels; dichotomous variables: incidence of anxiety, anorexia/decreased appetite/loss of appetite, insomnia, middle insomnia, abnormal dream, dizziness, tremor, headache, nausea, nasopharyngitis, diarrhea, constipation, increased serum antipsychotic, alanine aminotransferase, aspartate aminotransferase, eosinophil levels, and decreased serum neutrophil levels). If at least two studies in each drug group have sufficient data to conduct a meta‐analysis for a specific outcome, a meta‐analysis was conducted for those outcomes. For the efficacy outcome, we also assessed the statistical results derived from only one study.</p>
<p>Our meta‐analysis primarily used data based on the intention‐to‐treat or full analysis set principles. If required data were missing from the studies, we attempted to contact the original investigators to obtain unpublished data. However, we did not obtain the any unpublished data.</p></section></section><section id="npr270034-sec-0009"><h2 class="pmc_sec_title">3. Meta‐Analysis Methods</h2>
<p>ABT‐288, betahistine, betahistine + reboxetine, GSK239512, MK‐0249, and pitolisant were evaluated by our systematic review and meta‐analysis. Only betahistine has an H1‐receptor agonistic reaction and H3‐receptor antagonistic reaction [<a href="#npr270034-bib-0021" class="usa-link" aria-describedby="npr270034-bib-0021">21</a>], although other drugs only have H3‐receptor antagonistic/inverse agonistic reaction. Thus, as a difference in the receptor pharmacology between betahistine and others exists, we conducted a meta‐analysis for all outcomes divided by betahistine or other pooled H3R‐ANTs/H3R‐IAs. A random‐effects pairwise meta‐analysis was conducted based on the aforementioned outcomes to compare betahistine or other pooled H3R‐ANTs/H3R‐IAs with placebo [<a href="#npr270034-bib-0042" class="usa-link" aria-describedby="npr270034-bib-0042">42</a>]. The estimated standardized mean differences (SMD) in the continuous data and risk ratios (RR) for dichotomous data were calculated, with their respective 95% confidence intervals (CIs). The heterogeneity of the included trials was evaluated using the <em>I<sup>2</sup>
</em> statistic, with <em>I</em>
<sup>2</sup> ≥ 50% as considerable heterogeneity [<a href="#npr270034-bib-0024" class="usa-link" aria-describedby="npr270034-bib-0024">24</a>]. As lower scores (e.g., cognitive function scales and UPSA scores) indicate a higher impairment or symptom severity, the algebraic sign of the numerical scores for these scales was reversed. The risk of bias was evaluated using the Cochrane risk‐of‐bias tool for randomized trials version 2 [<a href="#npr270034-bib-0024" class="usa-link" aria-describedby="npr270034-bib-0024">24</a>]. To determine potential publication bias as funnel plots with &lt; 10 studies were not meaningful, Egger's test was performed [<a href="#npr270034-bib-0024" class="usa-link" aria-describedby="npr270034-bib-0024">24</a>]. Statistical analysis of our meta‐analysis was performed using Comprehensive Meta‐Analysis, version 4 (Biostat Inc., Englewood, NJ, USA).</p></section><section id="npr270034-sec-0010"><h2 class="pmc_sec_title">4. Results</h2>
<section id="npr270034-sec-0011"><h3 class="pmc_sec_title">4.1. Study Characteristics</h3>
<p>A total of 73 articles were retrieved during the initial search, of which 24 were discarded as duplicates. A review of the abstract and/or title of the remaining articles and trials ruled out 39 studies (Figure <a href="#npr270034-supitem-0001" class="usa-link">S1</a>). The clinical trial registries and the manual search did not reveal further trials. Finally, in our systematic review and meta‐analysis, 11 trials involving a total of 754 individuals were included (Figure <a href="#npr270034-supitem-0001" class="usa-link">S1</a>). A study by Smith et al. (2018) included two trials [<a href="#npr270034-bib-0022" class="usa-link" aria-describedby="npr270034-bib-0022">22</a>]. Two trials included ABT‐288 [<a href="#npr270034-bib-0013" class="usa-link" aria-describedby="npr270034-bib-0013">13</a>, <a href="#npr270034-bib-0016" class="usa-link" aria-describedby="npr270034-bib-0016">16</a>], one trial included GSK239512 [<a href="#npr270034-bib-0017" class="usa-link" aria-describedby="npr270034-bib-0017">17</a>], one trial included MK‐0249 [<a href="#npr270034-bib-0014" class="usa-link" aria-describedby="npr270034-bib-0014">14</a>], one trial included pitolisant [<a href="#npr270034-bib-0019" class="usa-link" aria-describedby="npr270034-bib-0019">19</a>], five trials included betahistine [<a href="#npr270034-bib-0015" class="usa-link" aria-describedby="npr270034-bib-0015">15</a>, <a href="#npr270034-bib-0018" class="usa-link" aria-describedby="npr270034-bib-0018">18</a>, <a href="#npr270034-bib-0020" class="usa-link" aria-describedby="npr270034-bib-0020">20</a>, <a href="#npr270034-bib-0022" class="usa-link" aria-describedby="npr270034-bib-0022">22</a>], and one trial included combination therapy of betahistine with reboxetine (betahistine+reboxetine) [<a href="#npr270034-bib-0021" class="usa-link" aria-describedby="npr270034-bib-0021">21</a>]. In Table <a href="#npr270034-tbl-0001" class="usa-link">1</a>, the study characteristics are illustrated. Two trials included adolescents and adults [<a href="#npr270034-bib-0020" class="usa-link" aria-describedby="npr270034-bib-0020">20</a>, <a href="#npr270034-bib-0022" class="usa-link" aria-describedby="npr270034-bib-0022">22</a>]. One trial only included individuals with first‐episode, drug‐naive schizophrenia and schizophreniform disorder [<a href="#npr270034-bib-0021" class="usa-link" aria-describedby="npr270034-bib-0021">21</a>]. Five trials were conducted in the USA [<a href="#npr270034-bib-0013" class="usa-link" aria-describedby="npr270034-bib-0013">13</a>, <a href="#npr270034-bib-0016" class="usa-link" aria-describedby="npr270034-bib-0016">16</a>, <a href="#npr270034-bib-0017" class="usa-link" aria-describedby="npr270034-bib-0017">17</a>, <a href="#npr270034-bib-0019" class="usa-link" aria-describedby="npr270034-bib-0019">19</a>, <a href="#npr270034-bib-0022" class="usa-link" aria-describedby="npr270034-bib-0022">22</a>], and three trials were conducted in China [<a href="#npr270034-bib-0015" class="usa-link" aria-describedby="npr270034-bib-0015">15</a>, <a href="#npr270034-bib-0018" class="usa-link" aria-describedby="npr270034-bib-0018">18</a>, <a href="#npr270034-bib-0022" class="usa-link" aria-describedby="npr270034-bib-0022">22</a>]. Although all trials included individuals with schizophrenia who received antipsychotics, six trials only included individuals who received second‐generation antipsychotics [<a href="#npr270034-bib-0013" class="usa-link" aria-describedby="npr270034-bib-0013">13</a>, <a href="#npr270034-bib-0015" class="usa-link" aria-describedby="npr270034-bib-0015">15</a>, <a href="#npr270034-bib-0016" class="usa-link" aria-describedby="npr270034-bib-0016">16</a>, <a href="#npr270034-bib-0018" class="usa-link" aria-describedby="npr270034-bib-0018">18</a>, <a href="#npr270034-bib-0020" class="usa-link" aria-describedby="npr270034-bib-0020">20</a>, <a href="#npr270034-bib-0021" class="usa-link" aria-describedby="npr270034-bib-0021">21</a>]. Six trials were not industry‐sponsored [<a href="#npr270034-bib-0015" class="usa-link" aria-describedby="npr270034-bib-0015">15</a>, <a href="#npr270034-bib-0018" class="usa-link" aria-describedby="npr270034-bib-0018">18</a>, <a href="#npr270034-bib-0019" class="usa-link" aria-describedby="npr270034-bib-0019">19</a>, <a href="#npr270034-bib-0021" class="usa-link" aria-describedby="npr270034-bib-0021">21</a>, <a href="#npr270034-bib-0022" class="usa-link" aria-describedby="npr270034-bib-0022">22</a>]. Most of the trials included were evaluated as having high risk or some concerns regarding the overall risk of bias (Figure <a href="#npr270034-supitem-0001" class="usa-link">S2</a>). As the Egan [<a href="#npr270034-bib-0014" class="usa-link" aria-describedby="npr270034-bib-0014">14</a>] study, which was a crossover study, did not report the first phase results (before crossover), this study was evaluated as having a high risk of bias in domain 2 (due to inappropriate analysis). As 21% of the participants in the Othman [<a href="#npr270034-bib-0013" class="usa-link" aria-describedby="npr270034-bib-0013">13</a>] study were participants in the same study twice, the study was evaluated as having a high risk of bias in domain 2 (due to inappropriate analysis). In our meta‐analysis, we did not include data from the Othman [<a href="#npr270034-bib-0013" class="usa-link" aria-describedby="npr270034-bib-0013">13</a>] study because there was no available data for the meta‐analysis.</p></section><section id="npr270034-sec-0012"><h3 class="pmc_sec_title">4.2. Systematic Review and Meta‐Analysis Results</h3>
<p>Betahistine outperformed placebo in terms of the improvement of overall cognitive symptoms (SMD [95% CI] = −0.61 (−1.03, −0.18)), speed of processing (−0.44 [−0.87, −0.02]), attention/vigilance (−0.43 [−0.85, −0.01]), working memory (−0.48 [−0.90, −0.06]), verbal learning (−0.62 [−1.04, −0.19]), and visual learning (−0.57 [−1.00, −0.15]) (Table <a href="#npr270034-tbl-0002" class="usa-link">2</a>). Betahistine + reboxetine outperformed placebo regarding the improvement of depressive symptoms (−4.04 [−5.10, −2.97]) (Table <a href="#npr270034-tbl-0002" class="usa-link">2</a>). However, the results were derived from one betahistine study [<a href="#npr270034-bib-0018" class="usa-link" aria-describedby="npr270034-bib-0018">18</a>] and betahistine+reboxetine [<a href="#npr270034-bib-0021" class="usa-link" aria-describedby="npr270034-bib-0021">21</a>]. Another study reported that pitolisant outperformed placebo regarding the improvement of depressive symptoms (SMD [95% CI] = −3.24 [−4.22, −2.26]) [<a href="#npr270034-bib-0019" class="usa-link" aria-describedby="npr270034-bib-0019">19</a>] (Table <a href="#npr270034-tbl-0002" class="usa-link">2</a>). One other study reported that ABT‐288 was inferior to placebo regarding the CGI‐S score (SMD [95% CI] = 0.31 [0.02, 0.61]) [<a href="#npr270034-bib-0016" class="usa-link" aria-describedby="npr270034-bib-0016">16</a>] (Table <a href="#npr270034-tbl-0002" class="usa-link">2</a>). Other pooled H3R‐ANTs/H3R‐IAs did not outperform placebo regarding any efficacy outcomes (Figure <a href="#npr270034-fig-0001" class="usa-link">1</a> and Table <a href="#npr270034-tbl-0002" class="usa-link">2</a>).</p>
<section class="tw xbox font-sm" id="npr270034-tbl-0002"><h4 class="obj_head">TABLE 2.</h4>
<div class="caption p"><p>The efficacy outcome results.</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<col align="left" span="1">
<col align="center" span="1">
<col align="center" span="1">
<col align="center" span="1">
<col align="center" span="1">
<col align="center" span="1">
<col align="center" span="1">
<col align="center" span="1">
<thead valign="bottom"><tr style="border-bottom:solid 1px #000000">
<th align="left" valign="bottom" rowspan="1" colspan="1">Outcome</th>
<th align="center" valign="bottom" rowspan="1" colspan="1">Drug<a href="#npr270034-note-0009" class="usa-link">
<sup>a</sup>
</a>
</th>
<th align="center" valign="bottom" rowspan="1" colspan="1">
<em>K</em>
</th>
<th align="center" valign="bottom" rowspan="1" colspan="1">
<em>n</em>
</th>
<th align="center" valign="bottom" rowspan="1" colspan="1">SMD</th>
<th align="center" valign="bottom" rowspan="1" colspan="1">95% CI</th>
<th align="center" valign="bottom" rowspan="1" colspan="1">
<em>p</em>
<a href="#npr270034-note-0109" class="usa-link">
<sup>b</sup>
</a>
</th>
<th align="center" valign="bottom" rowspan="1" colspan="1">Heterogeneity</th>
</tr></thead>
<tbody valign="top">
<tr>
<td align="left" rowspan="2" valign="top" colspan="1">Composite scores of the cognitive tests</td>
<td align="center" valign="top" rowspan="1" colspan="1">BET</td>
<td align="center" valign="top" rowspan="1" colspan="1">1</td>
<td align="center" valign="top" rowspan="1" colspan="1">89</td>
<td align="center" valign="top" rowspan="1" colspan="1">−0.61</td>
<td align="center" valign="top" rowspan="1" colspan="1">−1.03, −0.18</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<strong>0.01</strong>
</td>
<td align="center" valign="top" rowspan="1" colspan="1">na</td>
</tr>
<tr>
<td align="center" valign="top" rowspan="1" colspan="1">Others</td>
<td align="center" valign="top" rowspan="1" colspan="1">3</td>
<td align="center" valign="top" rowspan="1" colspan="1">322</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.11</td>
<td align="center" valign="top" rowspan="1" colspan="1">−0.11, 0.34</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.33</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<em>I</em>
<sup>2</sup> = 0.00%</td>
</tr>
<tr>
<td align="left" rowspan="2" valign="top" colspan="1">MCCB speed of the processing scores</td>
<td align="center" valign="top" rowspan="1" colspan="1">BET</td>
<td align="center" valign="top" rowspan="1" colspan="1">1</td>
<td align="center" valign="top" rowspan="1" colspan="1">89</td>
<td align="center" valign="top" rowspan="1" colspan="1">−0.44</td>
<td align="center" valign="top" rowspan="1" colspan="1">−0.87, −0.02</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<strong>0.04</strong>
</td>
<td align="center" valign="top" rowspan="1" colspan="1">na</td>
</tr>
<tr>
<td align="center" valign="top" rowspan="1" colspan="1">Others</td>
<td align="center" valign="top" rowspan="1" colspan="1">2</td>
<td align="center" valign="top" rowspan="1" colspan="1">229</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.15</td>
<td align="center" valign="top" rowspan="1" colspan="1">−0.47, 0.76</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.64</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<em>I</em>
<sup>2</sup> = 69.66%</td>
</tr>
<tr>
<td align="left" rowspan="2" valign="top" colspan="1">MCCB attention/vigilance scores</td>
<td align="center" valign="top" rowspan="1" colspan="1">BET</td>
<td align="center" valign="top" rowspan="1" colspan="1">1</td>
<td align="center" valign="top" rowspan="1" colspan="1">89</td>
<td align="center" valign="top" rowspan="1" colspan="1">−0.43</td>
<td align="center" valign="top" rowspan="1" colspan="1">−0.85, −0.01</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<strong>0.04</strong>
</td>
<td align="center" valign="top" rowspan="1" colspan="1">na</td>
</tr>
<tr>
<td align="center" valign="top" rowspan="1" colspan="1">Others</td>
<td align="center" valign="top" rowspan="1" colspan="1">2</td>
<td align="center" valign="top" rowspan="1" colspan="1">229</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.01</td>
<td align="center" valign="top" rowspan="1" colspan="1">−0.26, 0.28</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.95</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<em>I</em>
<sup>2</sup> = 0.00%</td>
</tr>
<tr>
<td align="left" rowspan="2" valign="top" colspan="1">Working memory scores</td>
<td align="center" valign="top" rowspan="1" colspan="1">BET</td>
<td align="center" valign="top" rowspan="1" colspan="1">1</td>
<td align="center" valign="top" rowspan="1" colspan="1">89</td>
<td align="center" valign="top" rowspan="1" colspan="1">−0.48</td>
<td align="center" valign="top" rowspan="1" colspan="1">−0.90, −0.06</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<strong>0.02</strong>
</td>
<td align="center" valign="top" rowspan="1" colspan="1">na</td>
</tr>
<tr>
<td align="center" valign="top" rowspan="1" colspan="1">Others</td>
<td align="center" valign="top" rowspan="1" colspan="1">3</td>
<td align="center" valign="top" rowspan="1" colspan="1">316</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.06</td>
<td align="center" valign="top" rowspan="1" colspan="1">−0.16, 0.29</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.59</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<em>I</em>
<sup>2</sup> = 0.00%</td>
</tr>
<tr>
<td align="left" rowspan="2" valign="top" colspan="1">MCCB verbal learning scores</td>
<td align="center" valign="top" rowspan="1" colspan="1">BET</td>
<td align="center" valign="top" rowspan="1" colspan="1">1</td>
<td align="center" valign="top" rowspan="1" colspan="1">89</td>
<td align="center" valign="top" rowspan="1" colspan="1">−0.62</td>
<td align="center" valign="top" rowspan="1" colspan="1">−1.04, −0.19</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<strong>0.00</strong>
<a href="#npr270034-note-0013" class="usa-link"><sup>*</sup></a>
</td>
<td align="center" valign="top" rowspan="1" colspan="1">na</td>
</tr>
<tr>
<td align="center" valign="top" rowspan="1" colspan="1">Others</td>
<td align="center" valign="top" rowspan="1" colspan="1">2</td>
<td align="center" valign="top" rowspan="1" colspan="1">229</td>
<td align="center" valign="top" rowspan="1" colspan="1">−0.02</td>
<td align="center" valign="top" rowspan="1" colspan="1">−0.39, 0.36</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.93</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<em>I</em>
<sup>2</sup> = 31.83%</td>
</tr>
<tr>
<td align="left" rowspan="2" valign="top" colspan="1">Visual learning scores</td>
<td align="center" valign="top" rowspan="1" colspan="1">BET</td>
<td align="center" valign="top" rowspan="1" colspan="1">1</td>
<td align="center" valign="top" rowspan="1" colspan="1">89</td>
<td align="center" valign="top" rowspan="1" colspan="1">−0.57</td>
<td align="center" valign="top" rowspan="1" colspan="1">−1.00, −0.15</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<strong>0.01</strong>
</td>
<td align="center" valign="top" rowspan="1" colspan="1">na</td>
</tr>
<tr>
<td align="center" valign="top" rowspan="1" colspan="1">Others</td>
<td align="center" valign="top" rowspan="1" colspan="1">3</td>
<td align="center" valign="top" rowspan="1" colspan="1">267</td>
<td align="center" valign="top" rowspan="1" colspan="1">−0.22</td>
<td align="center" valign="top" rowspan="1" colspan="1">−0.87, 0.43</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.51</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<em>I</em>
<sup>2</sup> = 78.36%</td>
</tr>
<tr>
<td align="left" rowspan="2" valign="top" colspan="1">MCCB reasoning/problem solving scores</td>
<td align="center" valign="top" rowspan="1" colspan="1">BET</td>
<td align="center" valign="top" rowspan="1" colspan="1">1</td>
<td align="center" valign="top" rowspan="1" colspan="1">89</td>
<td align="center" valign="top" rowspan="1" colspan="1">−0.41</td>
<td align="center" valign="top" rowspan="1" colspan="1">−0.83, 0.01</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.06</td>
<td align="center" valign="top" rowspan="1" colspan="1">na</td>
</tr>
<tr>
<td align="center" valign="top" rowspan="1" colspan="1">Others</td>
<td align="center" valign="top" rowspan="1" colspan="1">2</td>
<td align="center" valign="top" rowspan="1" colspan="1">229</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.16</td>
<td align="center" valign="top" rowspan="1" colspan="1">−0.11, 0.43</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.26</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<em>I</em>
<sup>2</sup> = 0.00%</td>
</tr>
<tr>
<td align="left" rowspan="2" valign="top" colspan="1">MCCB social cognition scores</td>
<td align="center" valign="top" rowspan="1" colspan="1">BET</td>
<td align="center" valign="top" rowspan="1" colspan="1">1</td>
<td align="center" valign="top" rowspan="1" colspan="1">89</td>
<td align="center" valign="top" rowspan="1" colspan="1">−0.28</td>
<td align="center" valign="top" rowspan="1" colspan="1">−0.69, 0.14</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.20</td>
<td align="center" valign="top" rowspan="1" colspan="1">na</td>
</tr>
<tr>
<td align="center" valign="top" rowspan="1" colspan="1">Others</td>
<td align="center" valign="top" rowspan="1" colspan="1">2</td>
<td align="center" valign="top" rowspan="1" colspan="1">229</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.25</td>
<td align="center" valign="top" rowspan="1" colspan="1">−0.02, 0.52</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.07</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<em>I</em>
<sup>2</sup> = 0.00%</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">UPSA scores</td>
<td align="center" valign="top" rowspan="1" colspan="1">Others</td>
<td align="center" valign="top" rowspan="1" colspan="1">2</td>
<td align="center" valign="top" rowspan="1" colspan="1">207</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.12</td>
<td align="center" valign="top" rowspan="1" colspan="1">−0.18, 0.41</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.45</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<em>I</em>
<sup>2</sup> = 5.24%</td>
</tr>
<tr>
<td align="left" rowspan="2" valign="top" colspan="1">Total symptom scores</td>
<td align="center" valign="top" rowspan="1" colspan="1">BET</td>
<td align="center" valign="top" rowspan="1" colspan="1">4</td>
<td align="center" valign="top" rowspan="1" colspan="1">249</td>
<td align="center" valign="top" rowspan="1" colspan="1">−0.11</td>
<td align="center" valign="top" rowspan="1" colspan="1">−0.36, 0.14</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.38</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<em>I</em>
<sup>2</sup> = 0.00%</td>
</tr>
<tr>
<td align="center" valign="top" rowspan="1" colspan="1">Others</td>
<td align="center" valign="top" rowspan="1" colspan="1">3</td>
<td align="center" valign="top" rowspan="1" colspan="1">324</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.09</td>
<td align="center" valign="top" rowspan="1" colspan="1">−0.16, 0.34</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.50</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<em>I</em>
<sup>2</sup> = 14.58%</td>
</tr>
<tr>
<td align="left" rowspan="2" valign="top" colspan="1">Positive symptom scores</td>
<td align="center" valign="top" rowspan="1" colspan="1">BET</td>
<td align="center" valign="top" rowspan="1" colspan="1">3</td>
<td align="center" valign="top" rowspan="1" colspan="1">226</td>
<td align="center" valign="top" rowspan="1" colspan="1">−0.22</td>
<td align="center" valign="top" rowspan="1" colspan="1">−0.48, 0.05</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.11</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<em>I</em>
<sup>2</sup> = 0.00%</td>
</tr>
<tr>
<td align="center" valign="top" rowspan="1" colspan="1">Other</td>
<td align="center" valign="top" rowspan="1" colspan="1">1</td>
<td align="center" valign="top" rowspan="1" colspan="1">94</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.13</td>
<td align="center" valign="top" rowspan="1" colspan="1">−0.28, 0.53</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.53</td>
<td align="center" valign="top" rowspan="1" colspan="1">na</td>
</tr>
<tr>
<td align="left" rowspan="2" valign="top" colspan="1">Negative symptom scores</td>
<td align="center" valign="top" rowspan="1" colspan="1">BET</td>
<td align="center" valign="top" rowspan="1" colspan="1">3</td>
<td align="center" valign="top" rowspan="1" colspan="1">226</td>
<td align="center" valign="top" rowspan="1" colspan="1">−0.11</td>
<td align="center" valign="top" rowspan="1" colspan="1">−0.38, 0.15</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.39</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<em>I</em>
<sup>2</sup> = 0.00%</td>
</tr>
<tr>
<td align="center" valign="top" rowspan="1" colspan="1">Others</td>
<td align="center" valign="top" rowspan="1" colspan="1">3</td>
<td align="center" valign="top" rowspan="1" colspan="1">334</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.02</td>
<td align="center" valign="top" rowspan="1" colspan="1">−0.22, 0.26</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.85</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<em>I</em>
<sup>2</sup> = 11.06%</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">PANSS general subscale scores</td>
<td align="center" valign="top" rowspan="1" colspan="1">BET</td>
<td align="center" valign="top" rowspan="1" colspan="1">2</td>
<td align="center" valign="top" rowspan="1" colspan="1">183</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.12</td>
<td align="center" valign="top" rowspan="1" colspan="1">−0.17, 0.41</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.42</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<em>I</em>
<sup>2</sup> = 0.00%</td>
</tr>
<tr>
<td align="left" rowspan="2" valign="top" colspan="1">Depressive symptom scores</td>
<td align="center" valign="top" rowspan="1" colspan="1">BET<a href="#npr270034-note-0010" class="usa-link">
<sup>c</sup>
</a>
</td>
<td align="center" valign="top" rowspan="1" colspan="1">1</td>
<td align="center" valign="top" rowspan="1" colspan="1">43</td>
<td align="center" valign="top" rowspan="1" colspan="1">−4.04</td>
<td align="center" valign="top" rowspan="1" colspan="1">−5.10, −2.97</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<strong>0.00</strong>
<a href="#npr270034-note-0014" class="usa-link"><sup>**</sup></a>
</td>
<td align="center" valign="top" rowspan="1" colspan="1">na</td>
</tr>
<tr>
<td align="center" valign="top" rowspan="1" colspan="1">Other<a href="#npr270034-note-0011" class="usa-link">
<sup>d</sup>
</a>
</td>
<td align="center" valign="top" rowspan="1" colspan="1">1</td>
<td align="center" valign="top" rowspan="1" colspan="1">38</td>
<td align="center" valign="top" rowspan="1" colspan="1">−3.24</td>
<td align="center" valign="top" rowspan="1" colspan="1">−4.22, −2.26</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<strong>0.00</strong>
<a href="#npr270034-note-0014" class="usa-link"><sup>**</sup></a>
</td>
<td align="center" valign="top" rowspan="1" colspan="1">na</td>
</tr>
<tr>
<td align="left" rowspan="2" valign="top" colspan="1">CGI‐S scores</td>
<td align="center" valign="top" rowspan="1" colspan="1">BET<a href="#npr270034-note-0010" class="usa-link">
<sup>c</sup>
</a>
</td>
<td align="center" valign="top" rowspan="1" colspan="1">1</td>
<td align="center" valign="top" rowspan="1" colspan="1">43</td>
<td align="center" valign="top" rowspan="1" colspan="1">−0.20</td>
<td align="center" valign="top" rowspan="1" colspan="1">−0.84, 0.44</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.55</td>
<td align="center" valign="top" rowspan="1" colspan="1">na</td>
</tr>
<tr>
<td align="center" valign="top" rowspan="1" colspan="1">Other<a href="#npr270034-note-0012" class="usa-link">
<sup>e</sup>
</a>
</td>
<td align="center" valign="top" rowspan="1" colspan="1">1</td>
<td align="center" valign="top" rowspan="1" colspan="1">198</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.31</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.02, 0.61</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<strong>0.04</strong>
</td>
<td align="center" valign="top" rowspan="1" colspan="1">na</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/npr270034-tbl-0002/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p">
<div class="fn" id="npr270034-note-0008"><p>Abbreviations: 95% CI, 95% confidence interval; BET, betahistine; CGI‐S, Clinical Global Impressions‐Severity; K, number of studies; MCCB, Measurement and Treatment Research to Improve Cognition in Schizophrenia Consensus Cognitive Battery; <em>n</em>, number of individuals; na, not applicable; PANSS, Positive and Negative Syndrome Scale; SMD, standardized mean difference; UPSA, University of California and San Diego Performance Based Skills Assessment.</p></div>
<div class="fn" id="npr270034-note-0009">
<sup>
<sup>a</sup>
</sup><p class="display-inline">Others: pooled histamine H3 receptor antagonist or inverse agonist other than betahistine.</p>
</div>
<div class="fn" id="npr270034-note-0109">
<sup>
<sup>b</sup>
</sup><p class="display-inline">Boldface indicates statistical significance.</p>
</div>
<div class="fn" id="npr270034-note-0010">
<sup>
<sup>c</sup>
</sup><p class="display-inline">Betahistine+reboxetine study.</p>
</div>
<div class="fn" id="npr270034-note-0011">
<sup>
<sup>d</sup>
</sup><p class="display-inline">Pitolisant study.</p>
</div>
<div class="fn" id="npr270034-note-0012">
<sup>
<sup>e</sup>
</sup><p class="display-inline">ABT‐288 study.</p>
</div>
<div class="fn" id="npr270034-note-0013">
<sup>*</sup><p class="display-inline">0.004.</p>
</div>
<div class="fn" id="npr270034-note-0014">
<sup>**</sup><p class="display-inline">&lt; 0.000000001.</p>
</div>
</div></section><figure class="fig xbox font-sm" id="npr270034-fig-0001"><h4 class="obj_head">FIGURE 1.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><img class="graphic" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/939e/12198695/3f5307de7927/NPR2-45-e70034-g001.jpg" loading="lazy" id="jats-graphic-3" height="1505" width="709" alt="FIGURE 1"></p>
<div class="p text-right font-secondary"><a href="figure/npr270034-fig-0001/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Forest plot of cognitive function for pooled H3R‐ANTs/H3R‐IAs other than betahistine. (a) Composite scores of the cognitive tests. (b) MCCB speed of the processing scores. (c) MCCB attention/vigilance scores. (d) Working memory scores. (e) MCCB verbal learning scores. (f) Visual learning scores. (g) MCCB reasoning/problem solving scores. (h) MCCB social cognition scores. 95% CI, 95% confidence interval; MCCB, Measurement and Treatment Research to Improve Cognition in Schizophrenia Consensus Cognitive Battery; PIT, pitolisant; Std diff in means, standardized difference in means.</p></figcaption></figure><p>Other pooled H3R‐ANTs/H3R‐IAs had a risk of insomnia (RR [95% CI] = 2.18 [1.05, 4.55]) (Table <a href="#npr270034-tbl-0003" class="usa-link">3</a>). However, no differences were found in terms of acceptability, tolerability, and other safety outcomes between betahistine or other pooled H3R‐ANTs/H3R‐IAs and placebo (Table <a href="#npr270034-tbl-0003" class="usa-link">3</a>).</p>
<section class="tw xbox font-sm" id="npr270034-tbl-0003"><h4 class="obj_head">TABLE 3.</h4>
<div class="caption p"><p>The results of the acceptability, tolerability, and safety outcomes.</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<col align="left" span="1">
<col align="center" span="1">
<col align="center" span="1">
<col align="center" span="1">
<col align="center" span="1">
<col align="center" span="1">
<col align="center" span="1">
<col align="center" span="1">
<thead valign="bottom">
<tr style="border-bottom:solid 1px #000000"><th align="left" colspan="8" valign="bottom" rowspan="1">Continuous variable</th></tr>
<tr style="border-bottom:solid 1px #000000">
<th align="left" valign="bottom" rowspan="1" colspan="1">Outcome</th>
<th align="center" valign="bottom" rowspan="1" colspan="1">Drug</th>
<th align="center" valign="bottom" rowspan="1" colspan="1">
<em>K</em>
</th>
<th align="center" valign="bottom" rowspan="1" colspan="1">
<em>n</em>
</th>
<th align="center" valign="bottom" rowspan="1" colspan="1">SMD</th>
<th align="center" valign="bottom" rowspan="1" colspan="1">95% CI</th>
<th align="center" valign="bottom" rowspan="1" colspan="1">
<em>p</em>
</th>
<th align="center" valign="bottom" rowspan="1" colspan="1">Heterogeneity</th>
</tr>
</thead>
<tbody valign="top">
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Body mass index</td>
<td align="center" valign="top" rowspan="1" colspan="1">BET</td>
<td align="center" valign="top" rowspan="1" colspan="1">3</td>
<td align="center" valign="top" rowspan="1" colspan="1">176</td>
<td align="center" valign="top" rowspan="1" colspan="1">−0.33</td>
<td align="center" valign="top" rowspan="1" colspan="1">−1.00, 0.34</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.34</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<em>I</em>
<sup>2</sup> = 76.275</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Body weight</td>
<td align="center" valign="top" rowspan="1" colspan="1">BET</td>
<td align="center" valign="top" rowspan="1" colspan="1">3</td>
<td align="center" valign="top" rowspan="1" colspan="1">176</td>
<td align="center" valign="top" rowspan="1" colspan="1">−0.28</td>
<td align="center" valign="top" rowspan="1" colspan="1">−0.96, 0.39</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.41</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<em>I</em>
<sup>2</sup> = 76.66%</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Waist circumference</td>
<td align="center" valign="top" rowspan="1" colspan="1">BET</td>
<td align="center" valign="top" rowspan="1" colspan="1">2</td>
<td align="center" valign="top" rowspan="1" colspan="1">133</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.13</td>
<td align="center" valign="top" rowspan="1" colspan="1">−0.21, 0.47</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.45</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<em>I</em>
<sup>2</sup> = 0.00%</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Hip circumference</td>
<td align="center" valign="top" rowspan="1" colspan="1">BET</td>
<td align="center" valign="top" rowspan="1" colspan="1">2</td>
<td align="center" valign="top" rowspan="1" colspan="1">133</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.18</td>
<td align="center" valign="top" rowspan="1" colspan="1">−0.16, 0.52</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.31</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<em>I</em>
<sup>2</sup> = 0.00%</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Serum triglyceride levels</td>
<td align="center" valign="top" rowspan="1" colspan="1">BET</td>
<td align="center" valign="top" rowspan="1" colspan="1">2</td>
<td align="center" valign="top" rowspan="1" colspan="1">122</td>
<td align="center" valign="top" rowspan="1" colspan="1">−0.15</td>
<td align="center" valign="top" rowspan="1" colspan="1">−0.51, 0.20</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.41</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<em>I</em>
<sup>2</sup> = 0.00%</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Serum low‐density lipoprotein cholesterol levels</td>
<td align="center" valign="top" rowspan="1" colspan="1">BET</td>
<td align="center" valign="top" rowspan="1" colspan="1">2</td>
<td align="center" valign="top" rowspan="1" colspan="1">122</td>
<td align="center" valign="top" rowspan="1" colspan="1">−0.09</td>
<td align="center" valign="top" rowspan="1" colspan="1">−0.45, 0.26</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.60</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<em>I</em>
<sup>2</sup> = 0.00%</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Serum total cholesterol levels</td>
<td align="center" valign="top" rowspan="1" colspan="1">BET</td>
<td align="center" valign="top" rowspan="1" colspan="1">2</td>
<td align="center" valign="top" rowspan="1" colspan="1">122</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.01</td>
<td align="center" valign="top" rowspan="1" colspan="1">−0.34, 0.37</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.95</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<em>I</em>
<sup>2</sup> = 0.00%</td>
</tr>
</tbody>
</table></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<col align="left" span="1">
<col align="center" span="1">
<col align="center" span="1">
<col align="center" span="1">
<col align="center" span="1">
<col align="center" span="1">
<col align="center" span="1">
<col align="center" span="1">
<thead valign="bottom">
<tr style="border-bottom:solid 1px #000000"><th align="left" colspan="8" valign="bottom" rowspan="1">Dichotomous variable</th></tr>
<tr style="border-bottom:solid 1px #000000">
<th align="left" valign="bottom" rowspan="1" colspan="1">Outcome</th>
<th align="center" valign="bottom" rowspan="1" colspan="1">Drug<a href="#npr270034-note-0016" class="usa-link">
<sup>a</sup>
</a>
</th>
<th align="center" valign="bottom" rowspan="1" colspan="1">
<em>K</em>
</th>
<th align="center" valign="bottom" rowspan="1" colspan="1">
<em>n</em>
</th>
<th align="center" valign="bottom" rowspan="1" colspan="1">RR</th>
<th align="center" valign="bottom" rowspan="1" colspan="1">95% CI</th>
<th align="center" valign="bottom" rowspan="1" colspan="1">
<em>p</em>
<a href="#npr270034-note-0116" class="usa-link">
<sup>b</sup>
</a>
</th>
<th align="center" valign="bottom" rowspan="1" colspan="1">Heterogeneity</th>
</tr>
</thead>
<tbody valign="top">
<tr>
<td align="left" rowspan="2" valign="top" colspan="1">All‐cause discontinuation</td>
<td align="center" valign="top" rowspan="1" colspan="1">BET</td>
<td align="center" valign="top" rowspan="1" colspan="1">5</td>
<td align="center" valign="top" rowspan="1" colspan="1">280</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.84</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.45, 1.58</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.59</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<em>I</em>
<sup>2</sup> = 21.25%</td>
</tr>
<tr>
<td align="center" valign="top" rowspan="1" colspan="1">Others</td>
<td align="center" valign="top" rowspan="1" colspan="1">4</td>
<td align="center" valign="top" rowspan="1" colspan="1">371</td>
<td align="center" valign="top" rowspan="1" colspan="1">1.54</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.97, 2.43</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.07</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<em>I</em>
<sup>2</sup> = 0.00%</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Discontinuation due to adverse events</td>
<td align="center" valign="top" rowspan="1" colspan="1">Others</td>
<td align="center" valign="top" rowspan="1" colspan="1">3</td>
<td align="center" valign="top" rowspan="1" colspan="1">318</td>
<td align="center" valign="top" rowspan="1" colspan="1">3.50</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.98, 12.53</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.05</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<em>I</em>
<sup>2</sup> = 0.00%</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Anxiety</td>
<td align="center" valign="top" rowspan="1" colspan="1">Others</td>
<td align="center" valign="top" rowspan="1" colspan="1">2</td>
<td align="center" valign="top" rowspan="1" colspan="1">316</td>
<td align="center" valign="top" rowspan="1" colspan="1">3.22</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.80, 12.95</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.10</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<em>I</em>
<sup>2</sup> = 0.00%</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Anorexia/decreased appetite/loss of appetite</td>
<td align="center" valign="top" rowspan="1" colspan="1">BET</td>
<td align="center" valign="top" rowspan="1" colspan="1">2</td>
<td align="center" valign="top" rowspan="1" colspan="1">128</td>
<td align="center" valign="top" rowspan="1" colspan="1">1.23</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.48, 3.15</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.67</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<em>I</em>
<sup>2</sup> = 0.00%</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Insomnia</td>
<td align="center" valign="top" rowspan="1" colspan="1">Others</td>
<td align="center" valign="top" rowspan="1" colspan="1">3</td>
<td align="center" valign="top" rowspan="1" colspan="1">366</td>
<td align="center" valign="top" rowspan="1" colspan="1">2.18</td>
<td align="center" valign="top" rowspan="1" colspan="1">1.05, 4.55</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<strong>0.04</strong>
</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<em>I</em>
<sup>2</sup> = 0.00%</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Middle insomnia</td>
<td align="center" valign="top" rowspan="1" colspan="1">Others</td>
<td align="center" valign="top" rowspan="1" colspan="1">2</td>
<td align="center" valign="top" rowspan="1" colspan="1">153</td>
<td align="center" valign="top" rowspan="1" colspan="1">2.00</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.45, 8.79</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.36</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<em>I</em>
<sup>2</sup> = 0.00%</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Abnormal dream</td>
<td align="center" valign="top" rowspan="1" colspan="1">Others</td>
<td align="center" valign="top" rowspan="1" colspan="1">2</td>
<td align="center" valign="top" rowspan="1" colspan="1">263</td>
<td align="center" valign="top" rowspan="1" colspan="1">1.78</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.44, 7.15</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.42</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<em>I</em>
<sup>2</sup> = 0.00%</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Dizziness</td>
<td align="center" valign="top" rowspan="1" colspan="1">Others</td>
<td align="center" valign="top" rowspan="1" colspan="1">2</td>
<td align="center" valign="top" rowspan="1" colspan="1">263</td>
<td align="center" valign="top" rowspan="1" colspan="1">2.92</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.77, 11.09</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.12</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<em>I</em>
<sup>2</sup> = 0.00%</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Tremor</td>
<td align="center" valign="top" rowspan="1" colspan="1">BET</td>
<td align="center" valign="top" rowspan="1" colspan="1">3</td>
<td align="center" valign="top" rowspan="1" colspan="1">164</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.94</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.36, 2.46</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.89</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<em>I</em>
<sup>2</sup> = 11.31%</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Headache</td>
<td align="center" valign="top" rowspan="1" colspan="1">Others</td>
<td align="center" valign="top" rowspan="1" colspan="1">3</td>
<td align="center" valign="top" rowspan="1" colspan="1">365</td>
<td align="center" valign="top" rowspan="1" colspan="1">1.68</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.79, 3.58</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.18</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<em>I</em>
<sup>2</sup> = 0.00%</td>
</tr>
<tr>
<td align="left" rowspan="2" valign="top" colspan="1">Nausea</td>
<td align="center" valign="top" rowspan="1" colspan="1">BET</td>
<td align="center" valign="top" rowspan="1" colspan="1">2</td>
<td align="center" valign="top" rowspan="1" colspan="1">128</td>
<td align="center" valign="top" rowspan="1" colspan="1">1.01</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.31, 3.31</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.99</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<em>I</em>
<sup>2</sup> = 0.00%</td>
</tr>
<tr>
<td align="center" valign="top" rowspan="1" colspan="1">Others</td>
<td align="center" valign="top" rowspan="1" colspan="1">3</td>
<td align="center" valign="top" rowspan="1" colspan="1">366</td>
<td align="center" valign="top" rowspan="1" colspan="1">1.35</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.40, 4.58</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.63</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<em>I</em>
<sup>2</sup> = 31.88%</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Nasopharyngitis</td>
<td align="center" valign="top" rowspan="1" colspan="1">Others</td>
<td align="center" valign="top" rowspan="1" colspan="1">2</td>
<td align="center" valign="top" rowspan="1" colspan="1">316</td>
<td align="center" valign="top" rowspan="1" colspan="1">1.08</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.29, 4.01</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.91</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<em>I</em>
<sup>2</sup> = 0.00%</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Diarrhea</td>
<td align="center" valign="top" rowspan="1" colspan="1">Others</td>
<td align="center" valign="top" rowspan="1" colspan="1">2</td>
<td align="center" valign="top" rowspan="1" colspan="1">263</td>
<td align="center" valign="top" rowspan="1" colspan="1">1.48</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.39, 5.57</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.57</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<em>I</em>
<sup>2</sup> = 0.00%</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Constipation</td>
<td align="center" valign="top" rowspan="1" colspan="1">BET</td>
<td align="center" valign="top" rowspan="1" colspan="1">2</td>
<td align="center" valign="top" rowspan="1" colspan="1">128</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.45</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.13, 1.57</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.21</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<em>I</em>
<sup>2</sup> = 58.13%</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Increased blood levels of antipsychotics</td>
<td align="center" valign="top" rowspan="1" colspan="1">BET</td>
<td align="center" valign="top" rowspan="1" colspan="1">2</td>
<td align="center" valign="top" rowspan="1" colspan="1">183</td>
<td align="center" valign="top" rowspan="1" colspan="1">2.97</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.31, 28.01</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.34</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<em>I</em>
<sup>2</sup> = 0.00%</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Increased blood levels of ALT</td>
<td align="center" valign="top" rowspan="1" colspan="1">Others</td>
<td align="center" valign="top" rowspan="1" colspan="1">2</td>
<td align="center" valign="top" rowspan="1" colspan="1">147</td>
<td align="center" valign="top" rowspan="1" colspan="1">1.32</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.19, 9.36</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.78</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<em>I</em>
<sup>2</sup> = 32.29%</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Increased blood levels of AST</td>
<td align="center" valign="top" rowspan="1" colspan="1">Others</td>
<td align="center" valign="top" rowspan="1" colspan="1">2</td>
<td align="center" valign="top" rowspan="1" colspan="1">147</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.50</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.07, 3.78</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.51</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<em>I</em>
<sup>2</sup> = 0.00%</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Increased blood levels of eosinophils</td>
<td align="center" valign="top" rowspan="1" colspan="1">Others</td>
<td align="center" valign="top" rowspan="1" colspan="1">2</td>
<td align="center" valign="top" rowspan="1" colspan="1">147</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.34</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.04, 3.19</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.35</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<em>I</em>
<sup>2</sup> = 0.00%</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Decreased blood levels of neutrophils</td>
<td align="center" valign="top" rowspan="1" colspan="1">Others</td>
<td align="center" valign="top" rowspan="1" colspan="1">2</td>
<td align="center" valign="top" rowspan="1" colspan="1">147</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.34</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.04, 3.19</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.35</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<em>I</em>
<sup>2</sup> = 0.00%</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/npr270034-tbl-0003/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p">
<div class="fn" id="npr270034-note-0015"><p>Abbreviations: 95% CI, 95% confidence interval; ALT, alanine aminotransferase; AST, aspartate aminotransferase; BET, betahistine; <em>K</em>, number of studies; LDL, low‐density lipoprotein; <em>n</em>, number of individuals; RR, risk ratio; SMD, standardized mean difference.</p></div>
<div class="fn" id="npr270034-note-0016">
<sup>
<sup>a</sup>
</sup><p class="display-inline">Others: histamine H3 receptor antagonist or inverse agonist other than betahistine.</p>
</div>
<div class="fn" id="npr270034-note-0116">
<sup>
<sup>b</sup>
</sup><p class="display-inline">Boldface indicates statistical significance.</p>
</div>
</div></section></section></section><section id="npr270034-sec-0013"><h2 class="pmc_sec_title">5. Discussion</h2>
<p>Our systematic review and meta‐analysis for individuals afflicted with schizophrenia showed that betahistine improves cognitive symptoms, and betahistine + reboxetine and pitolisant enhance depressive symptoms. Thus, we anticipate that these drugs may become novel candidate drugs for individuals with schizophrenia. However, each result was derived from only one trial [<a href="#npr270034-bib-0018" class="usa-link" aria-describedby="npr270034-bib-0018">18</a>, <a href="#npr270034-bib-0019" class="usa-link" aria-describedby="npr270034-bib-0019">19</a>, <a href="#npr270034-bib-0021" class="usa-link" aria-describedby="npr270034-bib-0021">21</a>]. Therefore, conducting another study to replicate the findings will be required to find robust evidence.</p>
<p>Pooled H3R‐ANTs/H3R‐IAs (MK‐0249, ABT‐288, and GSK239512) had a risk of insomnia. However, no differences were found in terms of acceptability, tolerability, and other safety outcomes between betahistine or other pooled H3R‐ANTs/H3R‐IAs and placebo. No studies of betahistine, betahistine + reboxetine, or pitolisant reported the incidence of insomnia. Thus, H3R‐ANTs/H3R‐IAs might have good overall acceptability and tolerability for schizophrenia.</p>
<p>Recent network meta‐analysis revealed that any antipsychotics failed to improve cognitive symptoms in people with schizophrenia [<a href="#npr270034-bib-0043" class="usa-link" aria-describedby="npr270034-bib-0043">43</a>]. Betahistine has an H1‐receptor agonistic and H3‐receptor antagonistic reaction and is indicated for the treatment of Meniere's disease, symptoms of which may include vertigo. H3‐receptor antagonistic reaction of betahistine increase the synaptic release of histamine and other neurotransmitters, including acetylcholine and glutamate [<a href="#npr270034-bib-0009" class="usa-link" aria-describedby="npr270034-bib-0009">9</a>], thereby improving synaptoplastic processes linked to cognitive function [<a href="#npr270034-bib-0010" class="usa-link" aria-describedby="npr270034-bib-0010">10</a>]. However, other pooled H3R‐ANTs/H3R‐IAs did not outperform placebo regarding any efficacy outcomes. Histaminergic H1 agonists promote wakefulness [<a href="#npr270034-bib-0044" class="usa-link" aria-describedby="npr270034-bib-0044">44</a>]. As several antipsychotics such as quetiapine, olanzapine, and clozapine have H1‐receptor antagonistic reaction, betahistine might improve cognitive symptoms in schizophrenia through reduced sedative effects associated with antipsychotics [<a href="#npr270034-bib-0003" class="usa-link" aria-describedby="npr270034-bib-0003">3</a>, <a href="#npr270034-bib-0045" class="usa-link" aria-describedby="npr270034-bib-0045">45</a>]. Additionally, most antipsychotics do not act on H3 receptors.</p>
<p>Our systematic review found that betahistine+reboxetine and pitolisant improved depressive symptoms in people with schizophrenia. Since reboxetine is an antidepressant [<a href="#npr270034-bib-0046" class="usa-link" aria-describedby="npr270034-bib-0046">46</a>], its antidepressant effect could influence the result. No differences were found in the results of all outcomes between a subgroup including only betahistine studies and another subgroup including betahistine studies and betahistine +reboxetine study (Table <a href="#npr270034-supitem-0001" class="usa-link">S3</a>). Pitolisant is a histamine‐3 receptor (H3R), a competitive antagonist and inverse agonist, acting through the histamine system to regulate wakefulness [<a href="#npr270034-bib-0047" class="usa-link" aria-describedby="npr270034-bib-0047">47</a>, <a href="#npr270034-bib-0048" class="usa-link" aria-describedby="npr270034-bib-0048">48</a>]. Other neurotransmitters are also modulated by pitolisant, increasing acetylcholine, noradrenaline, and dopamine release in the brain. The effects could enhance the depressive symptoms in schizophrenia [<a href="#npr270034-bib-0048" class="usa-link" aria-describedby="npr270034-bib-0048">48</a>].</p>
<p>ABT‐288 was inferior to placebo in terms of the CGI‐S score [<a href="#npr270034-bib-0016" class="usa-link" aria-describedby="npr270034-bib-0016">16</a>]. However, the result was derived from only one study. Moreover, as the appropriate dose of ABT‐288 for schizophrenia was unknown, the interpretation of the results should be exercised with caution.</p>
<p>However, our study had several limitations. First, the positive results were derived from only one study. Another limitation was the short study duration of each trial (2–16 weeks). A longer‐duration study using a larger sample is required as individuals with schizophrenia have a long‐term treatment period. Third, we did not explore which antipsychotics were compatible with betahistine or H3R‐ANTs/H3R‐IAs.</p>
<p>In conclusion, although our systematic review and meta‐analysis suggested that some H3R‐ANTs/H3R‐IAs appeared to have benefits for the treatment of cognitive symptoms and depressive symptoms in individuals with schizophrenia, the results were derived from only one trial. A replication randomized trial of the drugs should be conducted using a larger sample size.</p></section><section id="npr270034-sec-0020"><h2 class="pmc_sec_title">Author Contributions</h2>
<p>Dr. Yasufumi Nishii and Dr. Kenji Sakuma had complete access to all study data and is responsible for data integrity and analysis accuracy. Prof. Taro Kishi assisted in the conceptualization and design of the study. Dr. Yasufumi Nishii, Dr. Kenji Sakuma, and Prof. Taro Kishi performed the statistical analysis. The acquisition and interpretation of data were handled by Dr. Yasufumi Nishii, Dr. Kenji Sakuma, and Dr. Shun Hamanaka. The manuscript was written by all of the authors. The review was supervised by Prof. Nakao Iwata.</p></section><section id="npr270034-sec-0018"><h2 class="pmc_sec_title">Ethics Statement</h2>
<p>The authors have nothing to report.</p></section><section id="npr270034-sec-0019"><h2 class="pmc_sec_title">Consent</h2>
<p>The authors have nothing to report.</p></section><section id="npr270034-sec-0015"><h2 class="pmc_sec_title">Conflicts of Interest</h2>
<p>The authors declare no conflicts of interest related to the subject of this study. Interests for the past 3 years are as follows: Dr. Yasufumi Nishii has received speaker's honoraria from Sumitomo. Dr. Kenji Sakuma has received speaker's honoraria from Daiichi Sankyo, Janssen, Kyowa, Meiji, Mitsubishi‐Tanabe, Otsuka, Sumitomo, and Takeda and has received grants from JSPS KAKENHI (19K17099 and 23K06998), and Japan Agency for Medical Research and Development (JP22dk0307107, JP23dk0307122, JP24dk0307122, and JP25dk0307122). Dr. Shun Hamanaka has received speaker's honoraria from Sumitomo. Prof. Nakao Iwata received speaker's honoraria from Sumitomo, Eisai, Janssen, Otsuka, Meiji, Shionogi, Takeda, Yoshitomiyakuhin, and Viatris and research grants from Eisai, Takeda, Sumitomo, and Otsuka. Prof. Taro Kishi has received speaker's honoraria from Eisai, Janssen, Meiji, Otsuka, Sumitomo, Takeda, Mitsubishi‐Tanabe, Kyowa, Boehringer Ingelheim, and Viatris and research grants from Eisai, JSPS KAKENHI (19K08082 and 23K06998), Japan Agency for Medical Research and Development (JP22dk0307107, JP22wm0525024, 23dk0307117h0001, and 24dk0307129h0001), and the Japanese Ministry of Health, Labour and Welfare (21GC1018).</p></section><section id="sec18"><h2 class="pmc_sec_title">Supporting information</h2>
<section class="sm xbox font-sm" id="npr270034-supitem-0001"><div class="caption p"><p>
Data S1.
</p></div>
<div class="media p"><div class="caption">
<a href="/articles/instance/12198695/bin/NPR2-45-e70034-s001.docx" data-ga-action="click_feat_suppl" class="usa-link">NPR2-45-e70034-s001.docx</a><sup> (98.6KB, docx) </sup>
</div></div></section></section><section id="npr270034-sec-0014" class="ack"><h2 class="pmc_sec_title">Acknowledgments</h2>
<p>We acknowledge funding provided by JSPS KAKENHI (19K08082). We would like to thank MARUZEN‐YUSHODO Co. Ltd. (<a href="https://kw.maruzen.co.jp/kousei-honyaku/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://kw.maruzen.co.jp/kousei‐honyaku/</a>) for the English language editing.</p></section><section id="notes1"><p>

Nishii Y., Sakuma K., Hamanaka S., Iwata N., and Kishi T., “Efficacy and Safety of Histamine H3 Receptor Antagonist/Inverse Agonist Including Betahistine for Schizophrenia: A Systematic Review and Meta‐Analysis,” Neuropsychopharmacology Reports
45, no. 3 (2025): e70034, 10.1002/npr2.70034.
</p>
<section id="npr270034-ntgp-0001" class="fn-group"><div class="fn-group p font-secondary-light font-sm"><div class="fn p" id="npr270034-note-0001"><p>
<strong>Funding:</strong> We acknowledge funding provided by JSPS KAKENHI (19K08082). The funding source had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.</p></div></div></section></section><section id="_ci93_" lang="en" class="contrib-info"><h2 class="pmc_sec_title">Contributor Information</h2>
<p>Kenji Sakuma, Email: sakuma44@fujita-hu.ac.jp.</p>
<p>Taro Kishi, Email: tarok@fujita-hu.ac.jp.</p></section><section id="npr270034-sec-0017"><h2 class="pmc_sec_title">Data Availability Statement</h2>
<p>Data used for the current study were reported in articles as cited in this paper.</p></section><section id="npr270034-bibl-0001" class="ref-list"><h2 class="pmc_sec_title">References</h2>
<section id="npr270034-bibl-0001_sec2"><ul class="ref-list font-sm" style="list-style-type:none">
<li id="npr270034-bib-0001">
<span class="label">1.</span><cite>
van Os J. and Kapur S., “Schizophrenia,” Lancet
374, no. 9690 (2009): 635–645.
</cite> [<a href="https://doi.org/10.1016/S0140-6736(09)60995-8" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19700006/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Lancet&amp;title=Schizophrenia&amp;author=J.%20van%20Os&amp;author=S.%20Kapur&amp;volume=374&amp;issue=9690&amp;publication_year=2009&amp;pages=635-645&amp;pmid=19700006&amp;doi=10.1016/S0140-6736(09)60995-8&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="npr270034-bib-0002">
<span class="label">2.</span><cite>
American Psychiatric Association
, Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, Text Revision (DSM‐5‐TR) (American Psychiatric Association, 2022).</cite> [<a href="https://scholar.google.com/scholar_lookup?title=Diagnostic%20and%20Statistical%20Manual%20of%20Mental%20Disorders,%20Fifth%20Edition,%20Text%20Revision%20(DSM%E2%80%905%E2%80%90TR)&amp;publication_year=2022&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="npr270034-bib-0003">
<span class="label">3.</span><cite>
Huhn M., Nikolakopoulou A., Schneider‐Thoma J., et al., “Comparative Efficacy and Tolerability of 32 Oral Antipsychotics for the Acute Treatment of Adults With Multi‐Episode Schizophrenia: A Systematic Review and Network Meta‐Analysis,” Lancet
394, no. 10202 (2019): 939–951.
</cite> [<a href="https://doi.org/10.1016/S0140-6736(19)31135-3" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6891890/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31303314/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Lancet&amp;title=Comparative%20Efficacy%20and%20Tolerability%20of%2032%20Oral%20Antipsychotics%20for%20the%20Acute%20Treatment%20of%20Adults%20With%20Multi%E2%80%90Episode%20Schizophrenia:%20A%20Systematic%20Review%20and%20Network%20Meta%E2%80%90Analysis&amp;author=M.%20Huhn&amp;author=A.%20Nikolakopoulou&amp;author=J.%20Schneider%E2%80%90Thoma&amp;volume=394&amp;issue=10202&amp;publication_year=2019&amp;pages=939-951&amp;pmid=31303314&amp;doi=10.1016/S0140-6736(19)31135-3&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="npr270034-bib-0004">
<span class="label">4.</span><cite>
Kadakia A., Catillon M., Fan Q., et al., “The Economic Burden of Schizophrenia in the United States,” Journal of Clinical Psychiatry
83, no. 6 (2022): 22m14458.</cite> [<a href="https://doi.org/10.4088/JCP.22m14458" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36244006/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Clinical%20Psychiatry&amp;title=The%20Economic%20Burden%20of%20Schizophrenia%20in%20the%20United%20States&amp;author=A.%20Kadakia&amp;author=M.%20Catillon&amp;author=Q.%20Fan&amp;volume=83&amp;issue=6&amp;publication_year=2022&amp;pages=22m14458&amp;pmid=36244006&amp;doi=10.4088/JCP.22m14458&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="npr270034-bib-0005">
<span class="label">5.</span><cite>
Feber L., Peter N. L., Chiocchia V., et al., “Antipsychotic Drugs and Cognitive Function: A Systematic Review and Network Meta‐Analysis,” JAMA Psychiatry
82, no. 1 (2025): 47–56.
</cite> [<a href="https://doi.org/10.1001/jamapsychiatry.2024.2890" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11581732/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39412783/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=JAMA%20Psychiatry&amp;title=Antipsychotic%20Drugs%20and%20Cognitive%20Function:%20A%20Systematic%20Review%20and%20Network%20Meta%E2%80%90Analysis&amp;author=L.%20Feber&amp;author=N.%20L.%20Peter&amp;author=V.%20Chiocchia&amp;volume=82&amp;issue=1&amp;publication_year=2025&amp;pages=47-56&amp;pmid=39412783&amp;doi=10.1001/jamapsychiatry.2024.2890&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="npr270034-bib-0006">
<span class="label">6.</span><cite>
Kishi T., Ikuta T., Oya K., Matsunaga S., Matsuda Y., and Iwata N., “Anti‐Dementia Drugs for Psychopathology and Cognitive Impairment in Schizophrenia: A Systematic Review and Meta‐Analysis,” International Journal of Neuropsychopharmacology
21, no. 8 (2018): 748–757.
</cite> [<a href="https://doi.org/10.1093/ijnp/pyy045" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6070030/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29762677/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=International%20Journal%20of%20Neuropsychopharmacology&amp;title=Anti%E2%80%90Dementia%20Drugs%20for%20Psychopathology%20and%20Cognitive%20Impairment%20in%20Schizophrenia:%20A%20Systematic%20Review%20and%20Meta%E2%80%90Analysis&amp;author=T.%20Kishi&amp;author=T.%20Ikuta&amp;author=K.%20Oya&amp;author=S.%20Matsunaga&amp;author=Y.%20Matsuda&amp;volume=21&amp;issue=8&amp;publication_year=2018&amp;pages=748-757&amp;pmid=29762677&amp;doi=10.1093/ijnp/pyy045&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="npr270034-bib-0007">
<span class="label">7.</span><cite>
Lang F. U., Kosters M., Lang S., Becker T., and Jager M., “Psychopathological Long‐Term Outcome of Schizophrenia—A Review,” Acta Psychiatrica Scandinavica
127, no. 3 (2013): 173–182.
</cite> [<a href="https://doi.org/10.1111/acps.12030" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23136879/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Acta%20Psychiatrica%20Scandinavica&amp;title=Psychopathological%20Long%E2%80%90Term%20Outcome%20of%20Schizophrenia%E2%80%94A%20Review&amp;author=F.%20U.%20Lang&amp;author=M.%20Kosters&amp;author=S.%20Lang&amp;author=T.%20Becker&amp;author=M.%20Jager&amp;volume=127&amp;issue=3&amp;publication_year=2013&amp;pages=173-182&amp;pmid=23136879&amp;doi=10.1111/acps.12030&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="npr270034-bib-0008">
<span class="label">8.</span><cite>
Prell G. D., Green J. P., Kaufmann C. A., et al., “Histamine Metabolites in Cerebrospinal Fluid of Patients With Chronic Schizophrenia: Their Relationships to Levels of Other Aminergic Transmitters and Ratings of Symptoms,” Schizophrenia Research
14, no. 2 (1995): 93–104.
</cite> [<a href="https://doi.org/10.1016/0920-9964(94)00034-6" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/7711000/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Schizophrenia%20Research&amp;title=Histamine%20Metabolites%20in%20Cerebrospinal%20Fluid%20of%20Patients%20With%20Chronic%20Schizophrenia:%20Their%20Relationships%20to%20Levels%20of%20Other%20Aminergic%20Transmitters%20and%20Ratings%20of%20Symptoms&amp;author=G.%20D.%20Prell&amp;author=J.%20P.%20Green&amp;author=C.%20A.%20Kaufmann&amp;volume=14&amp;issue=2&amp;publication_year=1995&amp;pages=93-104&amp;pmid=7711000&amp;doi=10.1016/0920-9964(94)00034-6&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="npr270034-bib-0009">
<span class="label">9.</span><cite>
Nikolic K., Filipic S., Agbaba D., and Stark H., “Procognitive Properties of Drugs With Single and Multitargeting H3 Receptor Antagonist Activities,” CNS Neuroscience &amp; Therapeutics
20, no. 7 (2014): 613–623.
</cite> [<a href="https://doi.org/10.1111/cns.12279" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6493064/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24836924/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=CNS%20Neuroscience%20&amp;%20Therapeutics&amp;title=Procognitive%20Properties%20of%20Drugs%20With%20Single%20and%20Multitargeting%20H3%20Receptor%20Antagonist%20Activities&amp;author=K.%20Nikolic&amp;author=S.%20Filipic&amp;author=D.%20Agbaba&amp;author=H.%20Stark&amp;volume=20&amp;issue=7&amp;publication_year=2014&amp;pages=613-623&amp;pmid=24836924&amp;doi=10.1111/cns.12279&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="npr270034-bib-0010">
<span class="label">10.</span><cite>
Brioni J. D., Esbenshade T. A., Garrison T. R., Bitner S. R., and Cowart M. D., “Discovery of Histamine H3 Antagonists for the Treatment of Cognitive Disorders and Alzheimer's Disease,” Journal of Pharmacology and Experimental Therapeutics
336, no. 1 (2011): 38–46.
</cite> [<a href="https://doi.org/10.1124/jpet.110.166876" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20864505/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Pharmacology%20and%20Experimental%20Therapeutics&amp;title=Discovery%20of%20Histamine%20H3%20Antagonists%20for%20the%20Treatment%20of%20Cognitive%20Disorders%20and%20Alzheimer's%20Disease&amp;author=J.%20D.%20Brioni&amp;author=T.%20A.%20Esbenshade&amp;author=T.%20R.%20Garrison&amp;author=S.%20R.%20Bitner&amp;author=M.%20D.%20Cowart&amp;volume=336&amp;issue=1&amp;publication_year=2011&amp;pages=38-46&amp;pmid=20864505&amp;doi=10.1124/jpet.110.166876&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="npr270034-bib-0011">
<span class="label">11.</span><cite>
Vohora D. and Bhowmik M., “Histamine H3 Receptor Antagonists/Inverse Agonists on Cognitive and Motor Processes: Relevance to Alzheimer's Disease, ADHD, Schizophrenia, and Drug Abuse,” Frontiers in Systems Neuroscience
6 (2012): 72.
</cite> [<a href="https://doi.org/10.3389/fnsys.2012.00072" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3478588/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23109919/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Frontiers%20in%20Systems%20Neuroscience&amp;title=Histamine%20H3%20Receptor%20Antagonists/Inverse%20Agonists%20on%20Cognitive%20and%20Motor%20Processes:%20Relevance%20to%20Alzheimer's%20Disease,%20ADHD,%20Schizophrenia,%20and%20Drug%20Abuse&amp;author=D.%20Vohora&amp;author=M.%20Bhowmik&amp;volume=6&amp;publication_year=2012&amp;pages=72&amp;pmid=23109919&amp;doi=10.3389/fnsys.2012.00072&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="npr270034-bib-0012">
<span class="label">12.</span><cite>
Leucht S., Samara M., Heres S., and Davis J. M., “Dose Equivalents for Antipsychotic Drugs: The DDD Method,” Schizophrenia Bulletin
42, no. Suppl 1 (2016): S90–S94.
</cite> [<a href="https://doi.org/10.1093/schbul/sbv167" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4960429/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27460622/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Schizophrenia%20Bulletin&amp;title=Dose%20Equivalents%20for%20Antipsychotic%20Drugs:%20The%20DDD%20Method&amp;author=S.%20Leucht&amp;author=M.%20Samara&amp;author=S.%20Heres&amp;author=J.%20M.%20Davis&amp;volume=42&amp;issue=Suppl%201&amp;publication_year=2016&amp;pages=S90-S94&amp;pmid=27460622&amp;doi=10.1093/schbul/sbv167&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="npr270034-bib-0013">
<span class="label">13.</span><cite>
Othman A. A., Haig G., Florian H., Locke C., Gertsik L., and Dutta S., “The H3 Antagonist ABT‐288 Is Tolerated at Significantly Higher Exposures in Subjects With Schizophrenia Than in Healthy Volunteers,” British Journal of Clinical Pharmacology
77, no. 6 (2014): 965–974.
</cite> [<a href="https://doi.org/10.1111/bcp.12281" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4093922/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24215171/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=British%20Journal%20of%20Clinical%20Pharmacology&amp;title=The%20H3%20Antagonist%20ABT%E2%80%90288%20Is%20Tolerated%20at%20Significantly%20Higher%20Exposures%20in%20Subjects%20With%20Schizophrenia%20Than%20in%20Healthy%20Volunteers&amp;author=A.%20A.%20Othman&amp;author=G.%20Haig&amp;author=H.%20Florian&amp;author=C.%20Locke&amp;author=L.%20Gertsik&amp;volume=77&amp;issue=6&amp;publication_year=2014&amp;pages=965-974&amp;pmid=24215171&amp;doi=10.1111/bcp.12281&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="npr270034-bib-0014">
<span class="label">14.</span><cite>
Egan F., Zhao X., Gottwald R., et al., “Randomized Crossover Study of the Histamine H3 Inverse Agonist MK‐0249 for the Treatment of Cognitive Impairment in Patients With Schizophrenia,” Schizophrenia Research
146, no. 1–3 (2013): 224–230.
</cite> [<a href="https://doi.org/10.1016/j.schres.2013.02.030" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23523692/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Schizophrenia%20Research&amp;title=Randomized%20Crossover%20Study%20of%20the%20Histamine%20H3%20Inverse%20Agonist%20MK%E2%80%900249%20for%20the%20Treatment%20of%20Cognitive%20Impairment%20in%20Patients%20With%20Schizophrenia&amp;author=F.%20Egan&amp;author=X.%20Zhao&amp;author=R.%20Gottwald&amp;volume=146&amp;issue=1%E2%80%933&amp;publication_year=2013&amp;pages=224-230&amp;pmid=23523692&amp;doi=10.1016/j.schres.2013.02.030&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="npr270034-bib-0015">
<span class="label">15.</span><cite>
Bai L., Liang W., Wang Y., et al., “Effects of Adjunctive Betahistine Therapy on Lipid Metabolism in Patients With Chronic Schizophrenia: A Randomized Double‐Blind Placebo‐Controlled Study,” Neuropsychiatric Disease and Treatment
19 (2023): 453–460.
</cite> [<a href="https://doi.org/10.2147/NDT.S392770" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9984272/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36874957/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Neuropsychiatric%20Disease%20and%20Treatment&amp;title=Effects%20of%20Adjunctive%20Betahistine%20Therapy%20on%20Lipid%20Metabolism%20in%20Patients%20With%20Chronic%20Schizophrenia:%20A%20Randomized%20Double%E2%80%90Blind%20Placebo%E2%80%90Controlled%20Study&amp;author=L.%20Bai&amp;author=W.%20Liang&amp;author=Y.%20Wang&amp;volume=19&amp;publication_year=2023&amp;pages=453-460&amp;pmid=36874957&amp;doi=10.2147/NDT.S392770&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="npr270034-bib-0016">
<span class="label">16.</span><cite>
Haig G. M., Bain E., Robieson W., Othman A. A., Baker J., and Lenz R. A., “A Randomized Trial of the Efficacy and Safety of the H3 Antagonist ABT‐288 in Cognitive Impairment Associated With Schizophrenia,” Schizophrenia Bulletin
40, no. 6 (2014): 1433–1442.
</cite> [<a href="https://doi.org/10.1093/schbul/sbt240" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4193706/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24516190/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Schizophrenia%20Bulletin&amp;title=A%20Randomized%20Trial%20of%20the%20Efficacy%20and%20Safety%20of%20the%20H3%20Antagonist%20ABT%E2%80%90288%20in%20Cognitive%20Impairment%20Associated%20With%20Schizophrenia&amp;author=G.%20M.%20Haig&amp;author=E.%20Bain&amp;author=W.%20Robieson&amp;author=A.%20A.%20Othman&amp;author=J.%20Baker&amp;volume=40&amp;issue=6&amp;publication_year=2014&amp;pages=1433-1442&amp;pmid=24516190&amp;doi=10.1093/schbul/sbt240&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="npr270034-bib-0017">
<span class="label">17.</span><cite>
Jarskog L. F., Lowy M. T., Grove R. A., et al., “A Phase II Study of a Histamine H(3) Receptor Antagonist GSK239512 for Cognitive Impairment in Stable Schizophrenia Subjects on Antipsychotic Therapy,” Schizophrenia Research
164, no. 1–3 (2015): 136–142.
</cite> [<a href="https://doi.org/10.1016/j.schres.2015.01.041" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25728831/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Schizophrenia%20Research&amp;title=A%20Phase%20II%20Study%20of%20a%20Histamine%20H(3)%20Receptor%20Antagonist%20GSK239512%20for%20Cognitive%20Impairment%20in%20Stable%20Schizophrenia%20Subjects%20on%20Antipsychotic%20Therapy&amp;author=L.%20F.%20Jarskog&amp;author=M.%20T.%20Lowy&amp;author=R.%20A.%20Grove&amp;volume=164&amp;issue=1%E2%80%933&amp;publication_year=2015&amp;pages=136-142&amp;pmid=25728831&amp;doi=10.1016/j.schres.2015.01.041&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="npr270034-bib-0018">
<span class="label">18.</span><cite>
Wang Y., Huang X., Fan H., et al., “High‐Dose Betahistine Improves Cognitive Function in Patients With Schizophrenia: A Randomized Double‐Blind Placebo‐Controlled Trial,” Frontiers in Psychiatry
12 (2021): 762656.
</cite> [<a href="https://doi.org/10.3389/fpsyt.2021.762656" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8591287/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34790138/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Frontiers%20in%20Psychiatry&amp;title=High%E2%80%90Dose%20Betahistine%20Improves%20Cognitive%20Function%20in%20Patients%20With%20Schizophrenia:%20A%20Randomized%20Double%E2%80%90Blind%20Placebo%E2%80%90Controlled%20Trial&amp;author=Y.%20Wang&amp;author=X.%20Huang&amp;author=H.%20Fan&amp;volume=12&amp;publication_year=2021&amp;pages=762656&amp;pmid=34790138&amp;doi=10.3389/fpsyt.2021.762656&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="npr270034-bib-0019">
<span class="label">19.</span><cite>
<a href="https://clinicaltrials.gov/ct2/show/NCT00690274" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NCT00690274</a>
, “Study to Demonstrate Cognitive Enhancing Effects of BF2.649,” (2019).</cite>
</li>
<li id="npr270034-bib-0020">
<span class="label">20.</span><cite>
Barak N., Beck Y., and Albeck J. H., “A Randomized, Double‐Blind, Placebo‐Controlled Pilot Study of Betahistine to Counteract Olanzapine‐Associated Weight Gain,” Journal of Clinical Psychopharmacology
36, no. 3 (2016): 253–256.
</cite> [<a href="https://doi.org/10.1097/JCP.0000000000000489" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27028981/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Clinical%20Psychopharmacology&amp;title=A%20Randomized,%20Double%E2%80%90Blind,%20Placebo%E2%80%90Controlled%20Pilot%20Study%20of%20Betahistine%20to%20Counteract%20Olanzapine%E2%80%90Associated%20Weight%20Gain&amp;author=N.%20Barak&amp;author=Y.%20Beck&amp;author=J.%20H.%20Albeck&amp;volume=36&amp;issue=3&amp;publication_year=2016&amp;pages=253-256&amp;pmid=27028981&amp;doi=10.1097/JCP.0000000000000489&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="npr270034-bib-0021">
<span class="label">21.</span><cite>
Poyurovsky M., Fuchs C., Pashinian A., Levi A., Weizman R., and Weizman A., “Reducing Antipsychotic‐Induced Weight Gain in Schizophrenia: A Double‐Blind Placebo‐Controlled Study of Reboxetine‐Betahistine Combination,” Psychopharmacology
226, no. 3 (2013): 615–622.
</cite> [<a href="https://doi.org/10.1007/s00213-012-2935-2" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23239133/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Psychopharmacology&amp;title=Reducing%20Antipsychotic%E2%80%90Induced%20Weight%20Gain%20in%20Schizophrenia:%20A%20Double%E2%80%90Blind%20Placebo%E2%80%90Controlled%20Study%20of%20Reboxetine%E2%80%90Betahistine%20Combination&amp;author=M.%20Poyurovsky&amp;author=C.%20Fuchs&amp;author=A.%20Pashinian&amp;author=A.%20Levi&amp;author=R.%20Weizman&amp;volume=226&amp;issue=3&amp;publication_year=2013&amp;pages=615-622&amp;pmid=23239133&amp;doi=10.1007/s00213-012-2935-2&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="npr270034-bib-0022">
<span class="label">22.</span><cite>
Smith R. C., Maayan L., Wu R., et al., “Betahistine Effects on Weight‐Related Measures in Patients Treated With Antipsychotic Medications: A Double‐Blind Placebo‐Controlled Study,” Psychopharmacology (Berlin)
235, no. 12 (2018): 3545–3558.
</cite> [<a href="https://doi.org/10.1007/s00213-018-5079-1" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30382354/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Psychopharmacology%20(Berlin)&amp;title=Betahistine%20Effects%20on%20Weight%E2%80%90Related%20Measures%20in%20Patients%20Treated%20With%20Antipsychotic%20Medications:%20A%20Double%E2%80%90Blind%20Placebo%E2%80%90Controlled%20Study&amp;author=R.%20C.%20Smith&amp;author=L.%20Maayan&amp;author=R.%20Wu&amp;volume=235&amp;issue=12&amp;publication_year=2018&amp;pages=3545-3558&amp;pmid=30382354&amp;doi=10.1007/s00213-018-5079-1&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="npr270034-bib-0023">
<span class="label">23.</span><cite>
Green M. F., Nuechterlein K. H., Gold J. M., et al., “Approaching a Consensus Cognitive Battery for Clinical Trials in Schizophrenia: The NIMH‐MATRICS Conference to Select Cognitive Domains and Test Criteria,” Biological Psychiatry
56, no. 5 (2004): 301–307.
</cite> [<a href="https://doi.org/10.1016/j.biopsych.2004.06.023" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/15336511/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Biological%20Psychiatry&amp;title=Approaching%20a%20Consensus%20Cognitive%20Battery%20for%20Clinical%20Trials%20in%20Schizophrenia:%20The%20NIMH%E2%80%90MATRICS%20Conference%20to%20Select%20Cognitive%20Domains%20and%20Test%20Criteria&amp;author=M.%20F.%20Green&amp;author=K.%20H.%20Nuechterlein&amp;author=J.%20M.%20Gold&amp;volume=56&amp;issue=5&amp;publication_year=2004&amp;pages=301-307&amp;pmid=15336511&amp;doi=10.1016/j.biopsych.2004.06.023&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="npr270034-bib-0024">
<span class="label">24.</span><cite>
Higgins J., Thomas J., and Chandler J., Cochrane Handbook for Systematic Reviews of Interventions Version 6.3 (2022), <a href="https://www.trainingcochraneorg/handbook" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://www.trainingcochraneorg/handbook</a>.</cite> [<a href="https://scholar.google.com/scholar_lookup?title=Cochrane%20Handbook%20for%20Systematic%20Reviews%20of%20Interventions%20Version%206.3&amp;author=J.%20Higgins&amp;author=J.%20Thomas&amp;author=J.%20Chandler&amp;publication_year=2022&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="npr270034-bib-0025">
<span class="label">25.</span><cite>
Cohn L. D. and Becker B. J., “How Meta‐Analysis Increases Statistical Power,” Psychological Methods
8, no. 3 (2003): 243–253.
</cite> [<a href="https://doi.org/10.1037/1082-989X.8.3.243" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/14596489/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Psychological%20Methods&amp;title=How%20Meta%E2%80%90Analysis%20Increases%20Statistical%20Power&amp;author=L.%20D.%20Cohn&amp;author=B.%20J.%20Becker&amp;volume=8&amp;issue=3&amp;publication_year=2003&amp;pages=243-253&amp;pmid=14596489&amp;doi=10.1037/1082-989X.8.3.243&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="npr270034-bib-0026">
<span class="label">26.</span><cite>
Page M. J., McKenzie J. E., Bossuyt P. M., et al., “The PRISMA 2020 Statement: An Updated Guideline for Reporting Systematic Reviews,” British Medical Journal
372 (2021): n71.
</cite> [<a href="https://doi.org/10.1136/bmj.n71" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8005924/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33782057/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=British%20Medical%20Journal&amp;title=The%20PRISMA%202020%20Statement:%20An%20Updated%20Guideline%20for%20Reporting%20Systematic%20Reviews&amp;author=M.%20J.%20Page&amp;author=J.%20E.%20McKenzie&amp;author=P.%20M.%20Bossuyt&amp;volume=372&amp;publication_year=2021&amp;pages=n71&amp;pmid=33782057&amp;doi=10.1136/bmj.n71&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="npr270034-bib-0027">
<span class="label">27.</span><cite>
Kubo M., Kishi T., Matsunaga S., and Iwata N., “Histamine H3 Receptor Antagonists for Alzheimer's Disease: A Systematic Review and Meta‐Analysis of Randomized Placebo‐Controlled Trials,” Journal of Alzheimer's Disease
48, no. 3 (2015): 667–671.</cite> [<a href="https://doi.org/10.3233/JAD-150393" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26402104/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Alzheimer's%20Disease&amp;title=Histamine%20H3%20Receptor%20Antagonists%20for%20Alzheimer's%20Disease:%20A%20Systematic%20Review%20and%20Meta%E2%80%90Analysis%20of%20Randomized%20Placebo%E2%80%90Controlled%20Trials&amp;author=M.%20Kubo&amp;author=T.%20Kishi&amp;author=S.%20Matsunaga&amp;author=N.%20Iwata&amp;volume=48&amp;issue=3&amp;publication_year=2015&amp;pages=667-671&amp;pmid=26402104&amp;doi=10.3233/JAD-150393&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="npr270034-bib-0028">
<span class="label">28.</span><cite>
Sadek B., Saad A., Sadeq A., Jalal F., and Stark H., “Histamine H3 Receptor as a Potential Target for Cognitive Symptoms in Neuropsychiatric Diseases,” Behavioural Brain Research
312 (2016): 415–430.
</cite> [<a href="https://doi.org/10.1016/j.bbr.2016.06.051" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27363923/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Behavioural%20Brain%20Research&amp;title=Histamine%20H3%20Receptor%20as%20a%20Potential%20Target%20for%20Cognitive%20Symptoms%20in%20Neuropsychiatric%20Diseases&amp;author=B.%20Sadek&amp;author=A.%20Saad&amp;author=A.%20Sadeq&amp;author=F.%20Jalal&amp;author=H.%20Stark&amp;volume=312&amp;publication_year=2016&amp;pages=415-430&amp;pmid=27363923&amp;doi=10.1016/j.bbr.2016.06.051&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="npr270034-bib-0029">
<span class="label">29.</span><cite>
Ghamari N., Zarei O., Arias‐Montano J. A., et al., “Histamine H(3) Receptor Antagonists/Inverse Agonists: Where Do They Go?,” Pharmacology &amp; Therapeutics
200 (2019): 69–84.
</cite> [<a href="https://doi.org/10.1016/j.pharmthera.2019.04.007" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31028835/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Pharmacology%20&amp;%20Therapeutics&amp;title=Histamine%20H(3)%20Receptor%20Antagonists/Inverse%20Agonists:%20Where%20Do%20They%20Go?&amp;author=N.%20Ghamari&amp;author=O.%20Zarei&amp;author=J.%20A.%20Arias%E2%80%90Montano&amp;volume=200&amp;publication_year=2019&amp;pages=69-84&amp;pmid=31028835&amp;doi=10.1016/j.pharmthera.2019.04.007&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="npr270034-bib-0030">
<span class="label">30.</span><cite>
Keefe R. S., Goldberg T. E., Harvey P. D., Gold J. M., Poe M. P., and Coughenour L., “The Brief Assessment of Cognition in Schizophrenia: Reliability, Sensitivity, and Comparison With a Standard Neurocognitive Battery,” Schizophrenia Research
68, no. 2–3 (2004): 283–297.
</cite> [<a href="https://doi.org/10.1016/j.schres.2003.09.011" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/15099610/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Schizophrenia%20Research&amp;title=The%20Brief%20Assessment%20of%20Cognition%20in%20Schizophrenia:%20Reliability,%20Sensitivity,%20and%20Comparison%20With%20a%20Standard%20Neurocognitive%20Battery&amp;author=R.%20S.%20Keefe&amp;author=T.%20E.%20Goldberg&amp;author=P.%20D.%20Harvey&amp;author=J.%20M.%20Gold&amp;author=M.%20P.%20Poe&amp;volume=68&amp;issue=2%E2%80%933&amp;publication_year=2004&amp;pages=283-297&amp;pmid=15099610&amp;doi=10.1016/j.schres.2003.09.011&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="npr270034-bib-0031">
<span class="label">31.</span><cite>
CNB
, <a href="https://penncnp.med.upenn.edu" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://penncnp.med.upenn.edu</a>.</cite>
</li>
<li id="npr270034-bib-0032">
<span class="label">32.</span><cite>
Benedict R., Schretlen D., Groninger L., Dobraski M., and Shpritz B., “Revision of the Brief Visuospatial Memory Test: Studies of Normal Performance, Reliability, and Validity,” Psychological Assessment
8, no. 2 (1996): 145–153.</cite> [<a href="https://scholar.google.com/scholar_lookup?journal=Psychological%20Assessment&amp;title=Revision%20of%20the%20Brief%20Visuospatial%20Memory%20Test:%20Studies%20of%20Normal%20Performance,%20Reliability,%20and%20Validity&amp;author=R.%20Benedict&amp;author=D.%20Schretlen&amp;author=L.%20Groninger&amp;author=M.%20Dobraski&amp;author=B.%20Shpritz&amp;volume=8&amp;issue=2&amp;publication_year=1996&amp;pages=145-153&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="npr270034-bib-0033">
<span class="label">33.</span><cite>
Patterson T. L., Goldman S., McKibbin C. L., Hughs T., and Jeste D. V., “UCSD Performance‐Based Skills Assessment: Development of a New Measure of Everyday Functioning for Severely Mentally Ill Adults,” Schizophrenia Bulletin
27, no. 2 (2001): 235–245.
</cite> [<a href="https://doi.org/10.1093/oxfordjournals.schbul.a006870" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/11354591/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Schizophrenia%20Bulletin&amp;title=UCSD%20Performance%E2%80%90Based%20Skills%20Assessment:%20Development%20of%20a%20New%20Measure%20of%20Everyday%20Functioning%20for%20Severely%20Mentally%20Ill%20Adults&amp;author=T.%20L.%20Patterson&amp;author=S.%20Goldman&amp;author=C.%20L.%20McKibbin&amp;author=T.%20Hughs&amp;author=D.%20V.%20Jeste&amp;volume=27&amp;issue=2&amp;publication_year=2001&amp;pages=235-245&amp;pmid=11354591&amp;doi=10.1093/oxfordjournals.schbul.a006870&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="npr270034-bib-0034">
<span class="label">34.</span><cite>
Kay S. R., Opler L. A., and Lindenmayer J. P., “The Positive and Negative Syndrome Scale (PANSS): Rationale and Standardisation,” British Journal of Psychiatry, no. 7 (1989): 59–67.</cite> [<a href="https://pubmed.ncbi.nlm.nih.gov/2619982/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=British%20Journal%20of%20Psychiatry&amp;title=The%20Positive%20and%20Negative%20Syndrome%20Scale%20(PANSS):%20Rationale%20and%20Standardisation&amp;author=S.%20R.%20Kay&amp;author=L.%20A.%20Opler&amp;author=J.%20P.%20Lindenmayer&amp;issue=7&amp;publication_year=1989&amp;pages=59-67&amp;pmid=2619982&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="npr270034-bib-0035">
<span class="label">35.</span><cite>
Overall J. E. and Gorham D. R., “The Brief Psychiatric Rating Scale,” Psychological Reports
10 (1962): 799–812.</cite> [<a href="https://scholar.google.com/scholar_lookup?journal=Psychological%20Reports&amp;title=The%20Brief%20Psychiatric%20Rating%20Scale&amp;author=J.%20E.%20Overall&amp;author=D.%20R.%20Gorham&amp;volume=10&amp;publication_year=1962&amp;pages=799-812&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="npr270034-bib-0036">
<span class="label">36.</span><cite>
Andreasen N., Scale for the Assessment of Positive Symptoms (SAPS) (Univeristy of Iowa, 1984).</cite> [<a href="https://scholar.google.com/scholar_lookup?title=Scale%20for%20the%20Assessment%20of%20Positive%20Symptoms%20(SAPS)&amp;author=N.%20Andreasen&amp;publication_year=1984&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="npr270034-bib-0037">
<span class="label">37.</span><cite>
Andreasen N. C., “Negative Symptoms in Schizophrenia. Definition and Reliability,” Archives of General Psychiatry
39, no. 7 (1982): 784–788.
</cite> [<a href="https://doi.org/10.1001/archpsyc.1982.04290070020005" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/7165477/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Archives%20of%20General%20Psychiatry&amp;title=Negative%20Symptoms%20in%20Schizophrenia.%20Definition%20and%20Reliability&amp;author=N.%20C.%20Andreasen&amp;volume=39&amp;issue=7&amp;publication_year=1982&amp;pages=784-788&amp;pmid=7165477&amp;doi=10.1001/archpsyc.1982.04290070020005&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="npr270034-bib-0038">
<span class="label">38.</span><cite>
Alphs L. D., Summerfelt A., Lann H., and Muller R. J., “The Negative Symptom Assessment: A New Instrument to Assess Negative Symptoms of Schizophrenia,” Psychopharmacology Bulletin
25, no. 2 (1989): 159–163.
</cite> [<a href="https://pubmed.ncbi.nlm.nih.gov/2602512/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Psychopharmacology%20Bulletin&amp;title=The%20Negative%20Symptom%20Assessment:%20A%20New%20Instrument%20to%20Assess%20Negative%20Symptoms%20of%20Schizophrenia&amp;author=L.%20D.%20Alphs&amp;author=A.%20Summerfelt&amp;author=H.%20Lann&amp;author=R.%20J.%20Muller&amp;volume=25&amp;issue=2&amp;publication_year=1989&amp;pages=159-163&amp;pmid=2602512&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="npr270034-bib-0039">
<span class="label">39.</span><cite>
Hamilton M., “Development of a Rating Scale for Primary Depressive Illness,” British Journal of Social and Clinical Psychology
6, no. 4 (1967): 278–296.
</cite> [<a href="https://doi.org/10.1111/j.2044-8260.1967.tb00530.x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/6080235/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=British%20Journal%20of%20Social%20and%20Clinical%20Psychology&amp;title=Development%20of%20a%20Rating%20Scale%20for%20Primary%20Depressive%20Illness&amp;author=M.%20Hamilton&amp;volume=6&amp;issue=4&amp;publication_year=1967&amp;pages=278-296&amp;pmid=6080235&amp;doi=10.1111/j.2044-8260.1967.tb00530.x&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="npr270034-bib-0040">
<span class="label">40.</span><cite>
Montgomery S. A. and Asberg M., “A New Depression Scale Designed to Be Sensitive to Change,” British Journal of Psychiatry
134 (1979): 382–389.</cite> [<a href="https://doi.org/10.1192/bjp.134.4.382" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/444788/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=British%20Journal%20of%20Psychiatry&amp;title=A%20New%20Depression%20Scale%20Designed%20to%20Be%20Sensitive%20to%20Change&amp;author=S.%20A.%20Montgomery&amp;author=M.%20Asberg&amp;volume=134&amp;publication_year=1979&amp;pages=382-389&amp;pmid=444788&amp;doi=10.1192/bjp.134.4.382&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="npr270034-bib-0041">
<span class="label">41.</span><cite>
Guy W. and Bonato R. R., Manual for the ECDEU Assessment Battery (US Department of Health, Education, and Welfare, 1970).</cite> [<a href="https://scholar.google.com/scholar_lookup?title=Manual%20for%20the%20ECDEU%20Assessment%20Battery&amp;author=W.%20Guy&amp;author=R.%20R.%20Bonato&amp;publication_year=1970&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="npr270034-bib-0042">
<span class="label">42.</span><cite>
DerSimonian R. and Laird N., “Meta‐Analysis in Clinical Trials,” Controlled Clinical Trials
7, no. 3 (1986): 177–188.
</cite> [<a href="https://doi.org/10.1016/0197-2456(86)90046-2" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/3802833/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Controlled%20Clinical%20Trials&amp;title=Meta%E2%80%90Analysis%20in%20Clinical%20Trials&amp;author=R.%20DerSimonian&amp;author=N.%20Laird&amp;volume=7&amp;issue=3&amp;publication_year=1986&amp;pages=177-188&amp;pmid=3802833&amp;doi=10.1016/0197-2456(86)90046-2&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="npr270034-bib-0043">
<span class="label">43.</span><cite>
Feber L., Peter N. L., Chiocchia V., et al., “Antipsychotic Drugs and Cognitive Function: A Systematic Review and Pairwise Network Meta‐Analysis,” JAMA Psychiatry
82 (2024): 47–56.</cite> [<a href="https://doi.org/10.1001/jamapsychiatry.2024.2890" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11581732/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39412783/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=JAMA%20Psychiatry&amp;title=Antipsychotic%20Drugs%20and%20Cognitive%20Function:%20A%20Systematic%20Review%20and%20Pairwise%20Network%20Meta%E2%80%90Analysis&amp;author=L.%20Feber&amp;author=N.%20L.%20Peter&amp;author=V.%20Chiocchia&amp;volume=82&amp;publication_year=2024&amp;pages=47-56&amp;pmid=39412783&amp;doi=10.1001/jamapsychiatry.2024.2890&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="npr270034-bib-0044">
<span class="label">44.</span><cite>
Thakkar M. M., “Histamine in the Regulation of Wakefulness,” Sleep Medicine Reviews
15, no. 1 (2011): 65–74.
</cite> [<a href="https://doi.org/10.1016/j.smrv.2010.06.004" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3016451/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20851648/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Sleep%20Medicine%20Reviews&amp;title=Histamine%20in%20the%20Regulation%20of%20Wakefulness&amp;author=M.%20M.%20Thakkar&amp;volume=15&amp;issue=1&amp;publication_year=2011&amp;pages=65-74&amp;pmid=20851648&amp;doi=10.1016/j.smrv.2010.06.004&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="npr270034-bib-0045">
<span class="label">45.</span><cite>
Kishi T., Ikuta T., Sakuma K., Okuya M., and Iwata N., “Efficacy and Safety of Antipsychotic Treatments for Schizophrenia: A Systematic Review and Network Meta‐Analysis of Randomized Trials in Japan,” Journal of Psychiatric Research
138 (2021): 444–452.
</cite> [<a href="https://doi.org/10.1016/j.jpsychires.2021.04.032" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33964682/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Psychiatric%20Research&amp;title=Efficacy%20and%20Safety%20of%20Antipsychotic%20Treatments%20for%20Schizophrenia:%20A%20Systematic%20Review%20and%20Network%20Meta%E2%80%90Analysis%20of%20Randomized%20Trials%20in%20Japan&amp;author=T.%20Kishi&amp;author=T.%20Ikuta&amp;author=K.%20Sakuma&amp;author=M.%20Okuya&amp;author=N.%20Iwata&amp;volume=138&amp;publication_year=2021&amp;pages=444-452&amp;pmid=33964682&amp;doi=10.1016/j.jpsychires.2021.04.032&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="npr270034-bib-0046">
<span class="label">46.</span><cite>
Kishi T., Ikuta T., Sakuma K., et al., “Antidepressants for the Treatment of Adults With Major Depressive Disorder in the Maintenance Phase: A Systematic Review and Network Meta‐Analysis,” Molecular Psychiatry
28, no. 1 (2023): 402–409.
</cite> [<a href="https://doi.org/10.1038/s41380-022-01824-z" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9812779/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36253442/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Molecular%20Psychiatry&amp;title=Antidepressants%20for%20the%20Treatment%20of%20Adults%20With%20Major%20Depressive%20Disorder%20in%20the%20Maintenance%20Phase:%20A%20Systematic%20Review%20and%20Network%20Meta%E2%80%90Analysis&amp;author=T.%20Kishi&amp;author=T.%20Ikuta&amp;author=K.%20Sakuma&amp;volume=28&amp;issue=1&amp;publication_year=2023&amp;pages=402-409&amp;pmid=36253442&amp;doi=10.1038/s41380-022-01824-z&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="npr270034-bib-0047">
<span class="label">47.</span><cite>
The United States Food and Drug Administration (FDA)
, <a href="https://www.fda.gov/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://www.fda.gov/</a>.</cite>
</li>
<li id="npr270034-bib-0048">
<span class="label">48.</span><cite>
Sarfraz N., Okuampa D., Hansen H., et al., “Pitolisant, a Novel Histamine‐3 Receptor Competitive Antagonist, and Inverse Agonist, in the Treatment of Excessive Daytime Sleepiness in Adult Patients With Narcolepsy,” Health Psychology Research
10, no. 3 (2022): 34222.
</cite> [<a href="https://doi.org/10.52965/001c.34222" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9239364/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35774905/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Health%20Psychology%20Research&amp;title=Pitolisant,%20a%20Novel%20Histamine%E2%80%903%20Receptor%20Competitive%20Antagonist,%20and%20Inverse%20Agonist,%20in%20the%20Treatment%20of%20Excessive%20Daytime%20Sleepiness%20in%20Adult%20Patients%20With%20Narcolepsy&amp;author=N.%20Sarfraz&amp;author=D.%20Okuampa&amp;author=H.%20Hansen&amp;volume=10&amp;issue=3&amp;publication_year=2022&amp;pages=34222&amp;pmid=35774905&amp;doi=10.52965/001c.34222&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
</ul></section></section><section id="_ad93_" lang="en" class="associated-data"><h2 class="pmc_sec_title">Associated Data</h2>
<p class="font-secondary"><em>This section collects any data citations, data availability statements, or supplementary materials included in this article.</em></p>
<section id="_adsm93_" lang="en" class="supplementary-materials"><h3 class="pmc_sec_title">Supplementary Materials</h3>
<section class="sm xbox font-sm" id="db_ds_supplementary-material1_reqid_"><div class="caption p"><p>
Data S1.
</p></div>
<div class="media p"><div class="caption">
<a href="/articles/instance/12198695/bin/NPR2-45-e70034-s001.docx" data-ga-action="click_feat_suppl" class="usa-link">NPR2-45-e70034-s001.docx</a><sup> (98.6KB, docx) </sup>
</div></div></section></section><section id="_adda93_" lang="en" class="data-availability-statement"><h3 class="pmc_sec_title">Data Availability Statement</h3>
<p>Data used for the current study were reported in articles as cited in this paper.</p></section></section></section><footer class="p courtesy-note font-secondary font-sm text-center"><hr class="headless">
<p>Articles from Neuropsychopharmacology Reports are provided here courtesy of <strong>Wiley</strong></p></footer></section></article>

                      

                    </main>
                </div>
            </div>
        </div>

        



<!-- Secondary navigation placeholder -->
<div class="pmc-sidenav desktop:grid-col-4 display-flex">
    <section class="pmc-sidenav__container" aria-label="Article resources and navigation">
        <button type="button" class="usa-button pmc-sidenav__container__close usa-button--unstyled">
            <img src="/static/img/usa-icons/close.svg" role="img" alt="Close" />
        </button>
    <div class="display-none desktop:display-block">
       <section class="margin-top-4 desktop:margin-top-0">
              <h2 class="margin-top-0">ACTIONS</h2>
           <ul class="usa-list usa-list--unstyled usa-list--actions">
               
               <li>
                     <a
                             href="https://doi.org/10.1002/npr2.70034"
                             class="usa-button usa-button--outline width-24 font-xs display-inline-flex flex-align-center flex-justify-start padding-left-1"
                             target="_blank"
                             rel="noreferrer noopener"
                             data-ga-category="actions"
                             data-ga-action="click"
                             data-ga-label="publisher_link_desktop"
                     >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#launch"></use>
                         </svg>
                         <span class="display-inline-flex flex-justify-center flex-1 padding-right-2">View on publisher site</span>
                     </a>
               </li>
               
               
               <li>
                    <a
                            href="pdf/NPR2-45-e70034.pdf"
                            class="usa-button usa-button--outline width-24 display-inline-flex flex-align-center flex-justify-start padding-left-1"
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="pdf_download_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#file_download"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1">PDF (675.5 KB)</span>
                    </a>
               </li>
               
                
               <li>
                   <button role="button" class="usa-button width-24 citation-dialog-trigger display-inline-flex flex-align-center flex-justify-start padding-left-1"
                        aria-label="Open dialog with citation text in different styles"
                        data-ga-category="actions"
                        data-ga-action="open"
                        data-ga-label="cite_desktop"
                        data-all-citations-url="/resources/citations/12198695/"
                        data-citation-style="nlm"
                        data-download-format-link="/resources/citations/12198695/export/"
                    >
                        <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                        </svg>
                       <span class="display-inline-flex flex-justify-center flex-1 button-label">Cite</span>
                    </button>
               </li>
                
               <li>

                        <button class="usa-button width-24 collections-dialog-trigger collections-button display-inline-flex flex-align-center flex-justify-start padding-left-1 collections-button-empty"
                              aria-label="Save article in MyNCBI collections."
                              data-ga-category="actions"
                              data-ga-action="click"
                              data-ga-label="collections_button_desktop"
                              data-collections-open-dialog-enabled="false"
                              data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12198695%2F%3Freport%3Dclassic%23open-collections-dialog"
                              data-in-collections="false">
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                            <span class="display-inline-flex flex-justify-center flex-1">Collections</span>
                       </button>
               </li>
               <li class="pmc-permalink">
                    <button
                            type="button"
                            class="usa-button width-24 display-inline-flex flex-align-center flex-justify padding-left-1 shadow-none"
                            aria-label="Show article permalink"
                            aria-expanded="false"
                            aria-haspopup="true"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="permalink_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#share"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1 button-label">Permalink</span>
                    </button>
                   

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12198695/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
               </li>
           </ul>
       </section>
     </div>

        <section class="pmc-resources margin-top-6 desktop:margin-top-4" data-page-path="/articles/PMC12198695/">
            <h2 class="margin-top-0">RESOURCES</h2>
            
                <div class="usa-accordion usa-accordion--multiselectable" data-allow-multiple>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-similar-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_similar_articles"
                        data-ga-label="/articles/PMC12198695/"
                        data-action-open="open_similar_articles"
                        data-action-close="close_similar_articles"
                        >
                            Similar articles
                        </button>
                    </h3>
                    <div
                            id="resources-similar-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/similar-article-links/40567153/"
                            
                    >
                        
                    </div>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-cited-by-other-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_cited_by"
                        data-ga-label="/articles/PMC12198695/"
                        data-action-open="open_cited_by"
                        data-action-close="close_cited_by"
                        >
                             Cited by other articles
                        </button>
                    </h3>
                    <div
                            id="resources-cited-by-other-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/cited-by-links/40567153/"
                            
                    >
                          
                    </div>
                    
                        <h3 class="usa-accordion__heading">
                            <button
                            type="button"
                            class="usa-accordion__button"
                            aria-expanded="false"
                            aria-controls="resources-links-to-ncbi-databases"
                            data-ga-category="resources_accordion"
                            data-ga-action="open_NCBI_links"
                            data-ga-label="/articles/PMC12198695/"
                            data-action-open="open_NCBI_links"
                            data-action-close="close_NCBI_link"
                            >
                                 Links to NCBI Databases
                            </button>
                        </h3>
                        <div
                                id="resources-links-to-ncbi-databases"
                                class="usa-accordion__content usa-prose"
                                data-source-url="/resources/db-links/12198695/"
                        >
                        </div>
                    
                    
                </div>
            
        </section>


        <section
        class="usa-in-page-nav usa-in-page-nav--wide margin-top-6 desktop:margin-top-4"
        data-title-text="On this page"
        data-title-heading-level="h2"
        data-scroll-offset="0"
        data-root-margin="-10% 0px -80% 0px"
        data-main-content-selector="main"
        data-threshold="1"
        hidden
        ></section>
    </section>
</div>


        

<div class="overlay" role="dialog" aria-label="Citation Dialog" hidden>
    <div class="dialog citation-dialog" aria-hidden="true">
        <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
            <h2 class="usa-modal__heading margin-0">Cite</h2>
             <button type="button" class="usa-button usa-button--unstyled close-overlay text-black width-auto"  tabindex="1">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
             </button>
        </div>

        

<div class="citation-text-block">
  <div class="citation-text margin-bottom-2"></div>
  <ul class="usa-list usa-list--unstyled display-inline-flex flex-justify width-full flex-align-center">
      <li>
        <button
          class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center copy-button dialog-focus"
          data-ga-category="save_share"
          data-ga-action="cite"
          data-ga-label="copy"
          tabindex="2">
            <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                <use xlink:href="/static/img/sprite.svg#content_copy"></use>
            </svg>
            <span>Copy</span>
        </button>
      </li>
      <li>
          <a
              href="#"
              role="button"
              class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center export-button"
              data-ga-category="save_share"
              data-ga-action="cite"
              data-ga-label="download"
              title="Download a file for external citation management software"
              tabindex="3">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                </svg>
                <span class="display-none mobile-lg:display-inline">Download .nbib</span>
                <span class="display-inline mobile-lg:display-none">.nbib</span>
            </a>
      </li>
      <li>
          

<div class="display-inline-flex flex-align-center">
  <label class="usa-label margin-top-0">Format:</label>
  <select aria-label="Format" class="usa-select citation-style-selector padding-1 margin-top-0 border-0 padding-right-4" tabindex="4" >
    
      <option data-style-url-name="ama"
              value="AMA"
              >
        AMA
      </option>
    
      <option data-style-url-name="apa"
              value="APA"
              >
        APA
      </option>
    
      <option data-style-url-name="mla"
              value="MLA"
              >
        MLA
      </option>
    
      <option data-style-url-name="nlm"
              value="NLM"
              selected="selected">
        NLM
      </option>
    
  </select>
</div>
      </li>
  </ul>
</div>
    </div>
</div>

        <div class="overlay" role="dialog" hidden>
  <div id="collections-action-dialog" class="dialog collections-dialog" aria-hidden="true">
   <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
        <h2 class="usa-modal__heading margin-0">Add to Collections</h2>
    </div>
    <div class="collections-action-panel action-panel">
      


<form id="collections-action-dialog-form"
      class="usa-form maxw-full collections-action-panel-form action-panel-content action-form action-panel-smaller-selectors"
      data-existing-collections-url="/list-existing-collections/"
      data-add-to-existing-collection-url="/add-to-existing-collection/"
      data-create-and-add-to-new-collection-url="/create-and-add-to-new-collection/"
      data-myncbi-max-collection-name-length="100"
      data-collections-root-url="https://www.ncbi.nlm.nih.gov/myncbi/collections/">

    <input type="hidden" name="csrfmiddlewaretoken" value="DrwAEh80yRV9NfpbKk7cMDmqf6oyQMbale1YDdfkVKfrK4HIcGMKP6I4IYii0JkL">

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-new"
            class="usa-radio__input usa-radio__input--tile collections-new  margin-top-0"
            name="collections"
            value="new"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_new" />
            <label class="usa-radio__label" for="collections-action-dialog-new">Create a new collection</label>
        </div>
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-existing"
            class="usa-radio__input usa-radio__input--tile collections-existing"
            name="collections"
            value="existing"
            checked="true"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_existing" />
            <label class="usa-radio__label" for="collections-action-dialog-existing">Add to an existing collection</label>
        </div>
    </fieldset>

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="action-panel-control-wrap new-collections-controls">
           <label for="collections-action-dialog-add-to-new" class="usa-label margin-top-0">
                Name your collection
               <abbr title="required" class="usa-hint usa-hint--required text-no-underline">*</abbr>
          </label>
          <input
            type="text"
            name="add-to-new-collection"
            id="collections-action-dialog-add-to-new"
            class="usa-input collections-action-add-to-new"
            pattern="[^&quot;&amp;=&lt;&gt;/]*" title="The following characters are not allowed in the Name field: &quot;&amp;=&lt;&gt;/"
            maxlength=""
            data-ga-category="collections_button"
            data-ga-action="create_collection"
            data-ga-label="non_favorties_collection"
            required
          />
        </div>
        <div class="action-panel-control-wrap existing-collections-controls">
             <label for="collections-action-dialog-add-to-existing" class="usa-label margin-top-0">
                Choose a collection
              </label>
              <select id="collections-action-dialog-add-to-existing"
                      class="usa-select collections-action-add-to-existing"
                      data-ga-category="collections_button"
                      data-ga-action="select_collection"
                      data-ga-label="($('.collections-action-add-to-existing').val() === 'Favorites') ? 'Favorites' : 'non_favorites_collection'">
              </select>
              <div class="collections-retry-load-on-error usa-input-error-message selection-validation-message">
                Unable to load your collection due to an error<br>
                <a href="#">Please try again</a>
              </div>
        </div>
    </fieldset>

    <div class="display-inline-flex">
        <button class="usa-button margin-top-0 action-panel-submit"
            type="submit"
            data-loading-label="Adding..."
            data-pinger-ignore
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="add">
          Add
        </button>
        <button class="usa-button usa-button--outline margin-top-0 action-panel-cancel"
                aria-label="Close 'Add to Collections' panel"
                ref="linksrc=close_collections_panel"
                data-ga-category="collections_button"
                data-ga-action="click"
                data-ga-label="cancel">
          Cancel
        </button>
    </div>
</form>
    </div>
  </div>
</div>

        

      </div>
    </div>
  </div>



        
    
    

<footer class="ncbi-footer ncbi-dark-background " >
    
        <div class="ncbi-footer__icon-section">
            <div class="ncbi-footer__social-header">
                Follow NCBI
            </div>

            <div class="grid-container ncbi-footer__ncbi-social-icons-container">
                
                    <a href="https://twitter.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="40"
                             height="40"
                             viewBox="0 0 40 40"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on X (formerly known as Twitter)</span>
                    </a>
                

                
                    <a href="https://www.facebook.com/ncbi.nlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="16"
                             height="29"
                             focusable="false"
                             aria-hidden="true"
                             viewBox="0 0 16 29"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg">
                            <path d="M3.8809 21.4002C3.8809 19.0932 3.8809 16.7876 3.8809 14.478C3.8809 14.2117 3.80103 14.1452 3.54278 14.1492C2.53372 14.1638 1.52334 14.1492 0.514288 14.1598C0.302626 14.1598 0.248047 14.0972 0.248047 13.8936C0.256034 12.4585 0.256034 11.0239 0.248047 9.58978C0.248047 9.37013 0.302626 9.30224 0.528931 9.3049C1.53798 9.31688 2.54837 9.3049 3.55742 9.31555C3.80103 9.31555 3.8809 9.26097 3.87957 9.00272C3.87158 8.00565 3.85428 7.00592 3.90753 6.00884C3.97142 4.83339 4.31487 3.73115 5.04437 2.78467C5.93095 1.63318 7.15699 1.09005 8.56141 0.967577C10.5582 0.79319 12.555 0.982221 14.5518 0.927641C14.7102 0.927641 14.7462 0.99287 14.7449 1.13664C14.7449 2.581 14.7449 4.02668 14.7449 5.47104C14.7449 5.67604 14.6517 5.68669 14.4946 5.68669C13.4523 5.68669 12.4113 5.68669 11.3703 5.68669C10.3506 5.68669 9.92057 6.10868 9.90593 7.13904C9.89661 7.7647 9.91525 8.39303 9.89794 9.01869C9.88995 9.26364 9.96583 9.31822 10.2015 9.31688C11.7204 9.30623 13.2393 9.31688 14.7595 9.3049C15.0257 9.3049 15.0723 9.3728 15.0444 9.62439C14.89 10.9849 14.7515 12.3467 14.6144 13.7085C14.5691 14.1571 14.5785 14.1585 14.1458 14.1585C12.8386 14.1585 11.5313 14.1665 10.2254 14.1518C9.95119 14.1518 9.89794 14.2317 9.89794 14.4899C9.90593 19.0799 9.89794 23.6752 9.91125 28.2612C9.91125 28.5674 9.8407 28.646 9.53186 28.6433C7.77866 28.6273 6.02414 28.6366 4.27094 28.634C3.82499 28.634 3.87158 28.6992 3.87158 28.22C3.87602 25.9472 3.87913 23.6739 3.8809 21.4002Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on Facebook</span>
                    </a>
                

                
                    <a href="https://www.linkedin.com/company/ncbinlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="25"
                             height="23"
                             viewBox="0 0 26 24"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M14.6983 9.98423C15.6302 9.24808 16.5926 8.74754 17.6762 8.51991C19.673 8.09126 21.554 8.30824 23.1262 9.7526C24.2351 10.7723 24.7529 12.1115 25.0165 13.5612C25.1486 14.3363 25.2105 15.1218 25.2015 15.9081C25.2015 18.3043 25.2015 20.6898 25.2082 23.0806C25.2082 23.3468 25.1549 23.444 24.8621 23.4414C23.1297 23.4272 21.3992 23.4272 19.6704 23.4414C19.4041 23.4414 19.3429 23.3588 19.3442 23.1019C19.3535 20.5194 19.3442 17.9368 19.3442 15.3543C19.3442 14.0005 18.3258 12.9448 17.0266 12.9488C15.7273 12.9528 14.6983 14.0071 14.6983 15.361C14.6983 17.9328 14.6917 20.5047 14.6983 23.0753C14.6983 23.3708 14.6198 23.444 14.3296 23.4427C12.6185 23.4294 10.9079 23.4294 9.19779 23.4427C8.93155 23.4427 8.86099 23.3735 8.86232 23.1086C8.8783 19.7619 8.88628 16.4144 8.88628 13.066C8.88628 11.5688 8.87874 10.0708 8.86365 8.57182C8.86365 8.3575 8.90758 8.27896 9.14054 8.28029C10.9048 8.29094 12.6687 8.29094 14.4321 8.28029C14.6464 8.28029 14.6983 8.34818 14.6983 8.54653C14.6903 9.00047 14.6983 9.45441 14.6983 9.98423Z">
                            </path>
                            <path d="M6.55316 15.8443C6.55316 18.2564 6.55316 20.6699 6.55316 23.082C6.55316 23.3629 6.48127 23.4388 6.19906 23.4374C4.47737 23.4241 2.75568 23.4241 1.03399 23.4374C0.767751 23.4374 0.69986 23.3629 0.701191 23.1006C0.709178 18.2648 0.709178 13.4281 0.701191 8.59053C0.701191 8.34026 0.765089 8.27237 1.01669 8.2737C2.74991 8.28435 4.48048 8.28435 6.20838 8.2737C6.47462 8.2737 6.5465 8.33627 6.54517 8.6065C6.54783 11.0186 6.55316 13.4308 6.55316 15.8443Z">
                            </path>
                            <path d="M3.65878 0.243898C5.36804 0.243898 6.58743 1.45529 6.58743 3.1406C6.58743 4.75801 5.32145 5.95742 3.60819 5.96807C3.22177 5.97614 2.83768 5.90639 2.47877 5.76299C2.11985 5.61959 1.79344 5.40546 1.51897 5.13334C1.24449 4.86123 1.02755 4.53668 0.881058 4.17902C0.734563 3.82136 0.661505 3.43788 0.666231 3.05141C0.67555 1.42601 1.9362 0.242566 3.65878 0.243898Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on LinkedIn</span>
                    </a>
                

                
                    <a href="https://github.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="28"
                             height="27"
                             viewBox="0 0 28 28"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M16.7228 20.6334C17.5057 20.5527 18.2786 20.3944 19.0301 20.1608C21.3108 19.4193 22.5822 17.8259 22.963 15.4909C23.1228 14.5112 23.1814 13.5287 22.9883 12.5437C22.8106 11.6423 22.4013 10.8028 21.8007 10.1076C21.7526 10.0605 21.7197 10 21.7064 9.934C21.6931 9.86799 21.7 9.79952 21.7262 9.73748C22.0856 8.6206 21.9711 7.51969 21.601 6.42677C21.582 6.3497 21.5345 6.2827 21.468 6.23923C21.4016 6.19577 21.3211 6.17906 21.2429 6.19248C20.7329 6.21649 20.2313 6.33051 19.7611 6.52928C19.1103 6.7908 18.4899 7.12198 17.9104 7.51703C17.84 7.56996 17.7581 7.60551 17.6713 7.62078C17.5846 7.63605 17.4954 7.6306 17.4112 7.60489C15.2596 7.05882 13.0054 7.06203 10.8554 7.61421C10.7806 7.63586 10.7018 7.63967 10.6253 7.62534C10.5487 7.611 10.4766 7.57892 10.4148 7.53167C9.64788 7.03247 8.85171 6.58918 7.96368 6.33359C7.65781 6.24338 7.34123 6.19458 7.02239 6.18849C6.94879 6.17986 6.87462 6.19893 6.81432 6.242C6.75402 6.28507 6.71191 6.34904 6.69621 6.42145C6.32342 7.51437 6.2209 8.61527 6.56307 9.73348C6.59635 9.84264 6.64694 9.93316 6.54177 10.0516C5.47666 11.2604 5.09988 12.6834 5.19574 14.2676C5.2663 15.4244 5.46201 16.5466 6.01454 17.5769C6.84399 19.1171 8.21664 19.9119 9.85158 20.3352C10.3938 20.4706 10.9444 20.5698 11.4998 20.632C11.5384 20.7492 11.4506 20.7798 11.408 20.8291C11.1734 21.1179 10.9894 21.4441 10.8634 21.7942C10.7622 22.0458 10.8315 22.4039 10.6065 22.5516C10.263 22.7766 9.83827 22.8485 9.42421 22.8871C8.17936 23.0056 7.26471 22.4877 6.6283 21.4348C6.25552 20.8184 5.76956 20.3325 5.08523 20.0663C4.76981 19.9325 4.42139 19.8967 4.08537 19.9638C3.7898 20.029 3.73788 20.1901 3.93891 20.4111C4.03639 20.5234 4.14989 20.6207 4.27575 20.6999C4.9796 21.1318 5.51717 21.7884 5.80152 22.5636C6.37002 23.9973 7.48039 24.5697 8.93825 24.6323C9.43741 24.6575 9.93768 24.615 10.4254 24.5058C10.5892 24.4672 10.6531 24.4872 10.6517 24.6762C10.6451 25.4936 10.6637 26.3123 10.6517 27.131C10.6517 27.6635 10.1684 27.9297 9.58663 27.7393C8.17396 27.2671 6.84977 26.5631 5.66838 25.656C2.59555 23.2891 0.720966 20.1861 0.217704 16.3376C-0.357453 11.9127 0.911353 8.00824 3.98551 4.73881C6.11909 2.42656 8.99932 0.939975 12.1203 0.540191C16.5351 -0.0601815 20.4347 1.14323 23.7232 4.16373C26.2449 6.47869 27.724 9.37672 28.1048 12.7726C28.5828 17.0325 27.3686 20.7945 24.4768 23.9827C22.9762 25.6323 21.0956 26.8908 18.9982 27.6488C18.8783 27.6927 18.7585 27.738 18.636 27.7726C18.0356 27.9404 17.6189 27.6395 17.6189 27.0098C17.6189 25.7452 17.6308 24.4806 17.6295 23.2159C17.6329 22.9506 17.6128 22.6856 17.5696 22.4238C17.4325 21.6664 17.3419 21.484 16.7228 20.6334Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on GitHub</span>
                    </a>
                

                
                    <a href="https://ncbiinsights.ncbi.nlm.nih.gov/"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="26"
                             height="26"
                             viewBox="0 0 27 27"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M23.7778 26.4574C23.1354 26.3913 22.0856 26.8024 21.636 26.3087C21.212 25.8444 21.4359 24.8111 21.324 24.0347C19.9933 14.8323 14.8727 8.80132 6.09057 5.85008C4.37689 5.28406 2.58381 4.99533 0.779072 4.99481C0.202773 4.99481 -0.0229751 4.83146 0.00455514 4.21479C0.0660406 3.08627 0.0660406 1.95525 0.00455514 0.826734C-0.0413285 0.0815827 0.259669 -0.0193618 0.896534 0.00266238C6.96236 0.222904 12.3693 2.24179 16.9889 6.16209C22.9794 11.2478 26.1271 17.7688 26.4372 25.648C26.4629 26.294 26.3179 26.5271 25.6609 26.4684C25.0827 26.417 24.4991 26.4574 23.7778 26.4574Z">
                            </path>
                            <path d="M14.8265 26.441C14.0924 26.441 13.2371 26.6795 12.6626 26.3786C12.0092 26.0372 12.3781 25.0644 12.246 24.378C11.1154 18.5324 6.6849 14.5497 0.74755 14.1001C0.217135 14.0615 -0.0104482 13.9422 0.0134113 13.3659C0.0519536 12.1454 0.0482829 10.9213 0.0134113 9.69524C-0.00127145 9.14464 0.196946 9.03268 0.703502 9.04736C9.21217 9.27128 16.5994 16.2511 17.2804 24.7231C17.418 26.4446 17.418 26.4446 15.6579 26.4446H14.832L14.8265 26.441Z">
                            </path>
                            <path d="M3.58928 26.4555C2.64447 26.4618 1.73584 26.0925 1.06329 25.4289C0.39073 24.7653 0.00933763 23.8617 0.0030097 22.9169C-0.00331824 21.9721 0.365937 21.0635 1.02954 20.3909C1.69315 19.7184 2.59675 19.337 3.54156 19.3306C4.48637 19.3243 5.39499 19.6936 6.06755 20.3572C6.7401 21.0208 7.1215 21.9244 7.12782 22.8692C7.13415 23.814 6.7649 24.7226 6.10129 25.3952C5.43768 26.0677 4.53409 26.4491 3.58928 26.4555Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI RSS feed</span>
                    </a>
                
            </div>
        </div>
    

    <div data-testid="gridContainer"
         class="grid-container ncbi-footer__container">
        <div class="grid-row ncbi-footer__main-content-container"
             data-testid="grid">
            
                <div class="ncbi-footer__column">
                    
                        <p class="ncbi-footer__circled-icons-heading">
                            Connect with NLM
                        </p>
                    

                    <div class="ncbi-footer__circled-icons-list">
                        
                            <a href=https://twitter.com/nlm_nih class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="32"
                                     height="32"
                                     viewBox="0 0 40 40"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on X (formerly known as Twitter)</span>
                            </a>
                        

                        
                            <a href=https://www.facebook.com/nationallibraryofmedicine class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="13"
                                     height="24"
                                     viewBox="0 0 13 24"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M4.11371 23.1369C4.11371 23.082 4.11371 23.0294 4.11371 22.9745V12.9411H0.817305C0.6709 12.9411 0.670898 12.9411 0.670898 12.8016C0.670898 11.564 0.670898 10.3287 0.670898 9.09341C0.670898 8.97903 0.705213 8.95158 0.815017 8.95158C1.8673 8.95158 2.91959 8.95158 3.97417 8.95158H4.12057V8.83263C4.12057 7.8055 4.12057 6.7738 4.12057 5.74897C4.1264 4.92595 4.31387 4.11437 4.66959 3.37217C5.12916 2.38246 5.94651 1.60353 6.95717 1.1921C7.64827 0.905008 8.3913 0.764035 9.13953 0.778051C10.0019 0.791777 10.8644 0.830666 11.7268 0.860404C11.8869 0.860404 12.047 0.894717 12.2072 0.90158C12.2964 0.90158 12.3261 0.940469 12.3261 1.02968C12.3261 1.5421 12.3261 2.05452 12.3261 2.56465C12.3261 3.16857 12.3261 3.7725 12.3261 4.37642C12.3261 4.48165 12.2964 4.51367 12.1912 4.51138C11.5369 4.51138 10.8804 4.51138 10.2261 4.51138C9.92772 4.51814 9.63058 4.5526 9.33855 4.61433C9.08125 4.6617 8.84537 4.78881 8.66431 4.97766C8.48326 5.16652 8.3662 5.40755 8.32972 5.66661C8.28476 5.89271 8.26027 6.1224 8.25652 6.35289C8.25652 7.19014 8.25652 8.02969 8.25652 8.86923C8.25652 8.89439 8.25652 8.91955 8.25652 8.95615H12.0219C12.1797 8.95615 12.182 8.95616 12.1614 9.10714C12.0768 9.76596 11.9876 10.4248 11.9029 11.0813C11.8312 11.6319 11.7626 12.1824 11.697 12.733C11.6719 12.9434 11.6787 12.9434 11.4683 12.9434H8.26338V22.899C8.26338 22.979 8.26338 23.0591 8.26338 23.1392L4.11371 23.1369Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on Facebook</span>
                            </a>
                        

                        
                            <a href=https://www.youtube.com/user/NLMNIH class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="21"
                                     height="15"
                                     viewBox="0 0 21 15"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M19.2561 1.47914C18.9016 1.15888 18.5699 0.957569 17.2271 0.834039C15.5503 0.678484 13.2787 0.655608 11.563 0.65332H9.43556C7.71987 0.65332 5.4483 0.678484 3.77151 0.834039C2.43098 0.957569 2.097 1.15888 1.74242 1.47914C0.813665 2.32097 0.619221 4.62685 0.598633 6.89384C0.598633 7.31781 0.598633 7.74101 0.598633 8.16345C0.626084 10.4121 0.827391 12.686 1.74242 13.521C2.097 13.8412 2.4287 14.0425 3.77151 14.1661C5.4483 14.3216 7.71987 14.3445 9.43556 14.3468H11.563C13.2787 14.3468 15.5503 14.3216 17.2271 14.1661C18.5676 14.0425 18.9016 13.8412 19.2561 13.521C20.1712 12.6929 20.3725 10.451 20.3999 8.22064C20.3999 7.74025 20.3999 7.25986 20.3999 6.77946C20.3725 4.54907 20.1689 2.30724 19.2561 1.47914ZM8.55942 10.5311V4.65201L13.5601 7.50005L8.55942 10.5311Z"
                                          fill="white" />
                                </svg>
                                <span class="usa-sr-only">NLM on YouTube</span>
                            </a>
                        
                    </div>
                </div>
            

            
                <address class="ncbi-footer__address ncbi-footer__column">
                    
        <p>
            <a class="usa-link usa-link--external"
            href="https://www.google.com/maps/place/8600+Rockville+Pike,+Bethesda,+MD+20894/%4038.9959508,
            -77.101021,17z/data%3D!3m1!4b1!4m5!3m4!1s0x89b7c95e25765ddb%3A0x19156f88b27635b8!8m2!3d38.9959508!
            4d-77.0988323"
            rel="noopener noreferrer" target="_blank">National Library of Medicine
            <br/> 8600 Rockville Pike<br/> Bethesda, MD 20894</a>
        </p>
    
                </address>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            








<a href="https://www.nlm.nih.gov/web_policies.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
    

    Web Policies

    
</a>

                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            








<a href="https://www.nih.gov/institutes-nih/nih-office-director/office-communications-public-liaison/freedom-information-act-office" class="usa-link  usa-link--alt ncbi-footer__link"  >
    

    FOIA

    
</a>

                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            








<a href="https://www.hhs.gov/vulnerability-disclosure-policy/index.html" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
    

    HHS Vulnerability Disclosure

    
</a>

                        </li>
                    
                </ul>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            








<a href="https://support.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
    

    Help

    
</a>

                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            








<a href="https://www.nlm.nih.gov/accessibility.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
    

    Accessibility

    
</a>

                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            








<a href="https://www.nlm.nih.gov/careers/careers.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
    

    Careers

    
</a>

                        </li>
                    
                </ul>
            
        </div>

        
            <div class="grid-row grid-col-12" data-testid="grid">
                <ul class="ncbi-footer__bottom-links-list">
                    
                        <li class="ncbi-footer__bottom-list-item">
                            








<a href="https://www.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
    

    NLM

    
</a>

                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            








<a href="https://www.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
    

    NIH

    
</a>

                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            








<a href="https://www.hhs.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
    

    HHS

    
</a>

                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            








<a href="https://www.usa.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
    

    USA.gov

    
</a>

                        </li>
                    
                </ul>
            </div>
        
    </div>
</footer>

    


        
        
    
  <script  type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/pinger/pinger.js"> </script>


    
        

<button class="back-to-top" data-ga-category="pagination" data-ga-action="back_to_top">
    <label>Back to Top</label>
    <svg class="usa-icon order-0" aria-hidden="true" focusable="false" role="img">
        <use xlink:href="/static/img/sprite.svg#arrow_upward"></use>
    </svg>
</button>
    


        
    
    
    
        
    <script type="application/javascript">
    window.ncbi = window.ncbi || {};
    window.ncbi.pmc = window.ncbi.pmc || {};
    window.ncbi.pmc.options = {
        logLevel: 'INFO',
        
        staticEndpoint: '/static/',
        
        citeCookieName: 'pmc-cf',
    };
</script>
    <script type="module" crossorigin="" src="/static/assets/base-370d5dd6.js"></script>
    
    <script type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/jquery/jquery-3.6.0.min.js">&#xA0;</script>
    <script type="text/javascript">
        jQuery.getScript("https://cdn.ncbi.nlm.nih.gov/core/alerts/alerts.js", function () {
            galert(['div.nav_and_browser', 'div.header', '#universal_header', '.usa-banner', 'body > *:nth-child(1)'])
        });
    </script>


    <script type="text/javascript">var exports = {};</script>
     <script src="/static/CACHE/js/output.13b077bc3ffd.js"></script>

    <script type="module" crossorigin="" src="/static/assets/article-917ba005.js"></script>
    
    

    </body>
</html>
